Secondary Logo

Journal Logo

Dr Bizhan Aarabi

Dr Bizhan Aarabi is Professor of Neurosurgery at the University of Maryland and Director of Neurotrauma at the R. Adams Cowley Shock Trauma Center. Dr Aarabi is a graduate of Shiraz University School of Medicine (1967-1973). He completed his neurosurgical training at the Johns Hopkins Hospital. His research at Hopkins included dynamics of cold-induced brain edema in cat. From 1979 to 1995 Dr Aarabi was Professor and Chair, Department of Neurosurgery at the Shiraz University of Medical Sciences. From 1980 to 1988, while at the Shiraz University Medical School, Dr Aarabi studied vascular, infectious, and epileptic complications of penetrating brain injury in casualties from the Iran-Iraq war. In 1999, Drs Aarabi and Kaufman edited a two-volume book on “Missile Wounds of the Head and Neck.” Dr Aarabi has had fellowships from the University of Toronto and the University of Nebraska.

At the University of Maryland, Dr Aarabi has been the PI for multiple RCT trials funded by the North American Clinical Trial Network (NACTN). He has been one of the Guidelines Committee Members editing “The Guidelines for the Management of Acute Cervical Spine and Spinal Cord Injuries” and “Guidelines for the Management and Prognosis of Penetrating Brian Injury.” Dr Aarabi is a member of the AO Knowledge Forum Steering Committee in spinal cord injury. He has authored or co-authored more than 120 peer-reviewed articles. Dr Aarabi specializes in traumatic brain and spinal cord injuries, and his main clinical focus is MR characterization of acute cervical spinal cord injury.

Dr Aarabi has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.

ORCiD: 0000-0001-8071-457X


Owoicho Adogwa, MD, MPH

Owoicho Adogwa, MD, MPH, is an Assistant Professor in the Department of Neurological Surgery at UT Southwestern Medical Center. He focuses on the treatment of spinal diseases, with primary expertise in adult and pediatric scoliosis, degenerative spinal pathologies, and spinal oncology. He is a specialist both in advanced minimally invasive and traditional open techniques.

After earning his medical degree at Vanderbilt University School of Medicine, Dr Adogwa completed his residencies in neurological surgery at Duke University Medical Center and Rush University Medical Center. During his residency at RUSH, he completed an advanced complex spine and minimally invasive spine surgery fellowship under internationally renowned spine surgeons Vincent Traynelis, MD, and Richard Fessler, MD Post-residency, he completed an adult and pediatric deformity fellowship at Washington University in St. Louis, where he trained under the direction of world-renowned surgeons Munish Gupta, MD, Keith Bridwell, MD, Michael Kelly, MD, Jacob Buchowski, MD, and others. Dr Adogwa then pursued additional surgical training in advanced osteotomy techniques in Lyon, France, under the tutelage of Pierre Roussouly, MD, and in Accra, Ghana, under the mentorship of Oheneba Boachie, MD (founder of FOCOS Hospital and past president of the Scoliosis Research Society).

Given this background, Dr Adogwa is one of only a few surgeons in the world who is cross-trained in both orthopedic spine surgery and neurosurgery, which has provided him with unique qualifications to treat patients with complex spinal conditions, bringing to each patient the expertise necessary to evaluate and, if required, surgically treat disorders of the spine.

Dr Adogwa is a prolific surgeon-scientist, having published more than 180 peer-reviewed scientific papers and book chapters and presented as an invited speaker, program faculty, or guest lecturer at more than 160 scientific meetings across the world.

He has served on the editorial board of numerous scientific journals, including as Deputy Editor of The Spine Journal, and is a reviewer for more than 20 neurosurgery and orthopedic journals.

He has held numerous leadership positions in neurosurgery and spine surgery organizations and is a member of the Congress of Neurological Surgeons, the North American Spine Society, the American Association of Neurological Surgeons, the Lumbar Spine Research Society, AO Spine, the Scoliosis Research Society, the Texas Medical Association, the Dallas Medical Association, the American College of Surgeons, and the Council of State Neurological Societies. Dr Adogwa has no conflicts of interest.


Siviero Agazzi

Italian born and Swiss trained, Siviero Agazzi obtained the Swiss Board Certification in Neurological Surgery in 2002. He pursued advanced training in complex cranial surgery by completing a fellowship in Skull Base and Cerebrovascular Surgery at the University of South Florida where, in 2005 he was invited to join the faculty. In 2010 he obtained an MBA degree from the USF Muma College of Business.

Dr Agazzi is the Director of the Division of Cranial Surgery, at the University of South Florida Department of Neurosurgery. His clinical and research focus is on vestibular schwannomas and his surgical practice includes convexity and skull base meningiomas, endoscopic transnasal and intraventricular surgery and open vascular surgical procedures (aneurysms, AVMs and vascular bypass).

Dr Agazzi is the current director of the USF Complex Cranial Surgery fellowship. Limited to one fellow per year, this fellowship provides an in depth exposure to both skull base tumors as well as open vascular neurosurgery including aneurysms, AVMs and EC-IC bypass. Over the past 13 years, this fellowship has successfully prepared young neurosurgeon for academic positions in complex cranial surgery.

Dr Agazzi is married and has 2 children. He enjoys competing in triathlons (age group category), Kiteboarding on the Tampa Bay waters and Skiing in the Alps or Rockies.

Dr Agazzi has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.

ORCiD: 0000-0001-5760-0187


Faiz Ahmad MD, MCh

Faiz Ahmad MD, MCh, is an Assistant Professor of Neurological Surgery at the Emory University School of Medicine. He completed his neurosurgical residency and two fellowships at the University of Miami Miller School of Medicine, including a complex spinal surgery fellowship.

Dr Ahmad serves as the Director of Spinal Neurosurgery and Surgical Neuro-trauma at Grady Memorial Hospital, Atlanta, one of the country's largest trauma centers and public hospitals. His specialty interests include minimally invasive methods of treating spinal disorders, treatment of spinal tumors, artificial cervical disc replacement, use of computer-assisted navigation techniques in spinal surgery, complex spinal reconstruction surgery, and spinal cord injury.

Dr Ahmad is a prolific researcher, publishing over 150 peer-reviewed papers, book chapters, abstracts, and presentations. His research interests include spinal injury, minimally invasive neurosurgery, and traumatic brain injury. He also serves has an editor and reviewer for several national and international peer-reviewed scientific journals. He loves teaching and has received several neurosurgery research and teaching awards in his career.

Dr Ahmad is a Consultant for Consultant (on a fee on per use basis)- Medtronic, Depuy- Synthes, Stryker Spine and MiRus


Jason W. Allen, MD, PhD

Jason W. Allen, MD, PhD is an assistant professor in the departments of radiology and imaging sciences and neurology at Emory University. He is also the assistant chief of radiology at Grady Memorial Hospital and the medical director of the Emory University Center for Systems Imaging, a core imaging facility.

Dr Allen earned both his MD and PhD in neuroscience from Georgetown University. He then completed a combined neurology/radiology/neuroradiology program at New York University School of Medicine and is board-certified in both diagnostic radiology and neurology, as well as having a Certificate of Additional Qualification in Neuroradiology. His previous research involved animal models of traumatic brain injury (TBI), focusing on elucidating the underlying pathophysiologic mechanisms of traumatic neuronal injury as well as investigating potential novel therapeutic agents. This included early work in the role and possible modulation of trauma-induced apoptosis, particularly that mediated by metabotropoic glutamate receptors. Dr Allen’s current research interests are centered on the imaging characteristics of human neuronal injury, in particular TBI, using advanced magnetic resonance imaging techniques such as diffusion tensor, diffusion kurtosis, and functional MR imaging. Dr Allen also investigates clinical questions such as the use of advanced imaging techniques in the evaluation of cerebral infarction, trauma, and subarachnoid hemorrhage.

Dr Allen has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.

ORCiD: 0000-0002-5274-1105


Michelle Alonso-Basanta, MD, PhD

Michelle Alonso-Basanta, MD, PhD, is the board-certified Associate Professor of Radiation Oncology at the Perelman School of Medicine, University of Pennsylvania. She is the Vice Chair of the Clinical Division and Section Chief for Central Nervous System Tumors at Penn Medicine. She received her undergraduate degree in Chemistry from New York University (NYU) where she also completed her MD/PhD. She completed her residency in radiation oncology at NYU where she was Chief Resident. Dr Alonso-Basanta specializes in diseases of the central nervous system, base of skull, head and neck and spine, including expertise in stereotactic cranial and extracranial radiotherapy. She is trained in image-guided, intensity modulated radiotherapy, proton radiotherapy, stereotactic radiosurgery (gamma knife radiosurgery) and stereotactic radiotherapy. Her clinical and research interests include normal tissue sparing and prevention and management of long term effects in patients with central nervous system tumors.

Dr Alonso-Basanta received travel and lodging from IBA/Bioterra for speaking and received an Honorarium from Varian

ORCiD: 000-0001-9214-7656


Dr Christopher P. Ames

Dr Christopher P. Ames is the director of spinal deformity and spine tumor surgery and co-director of the combined high risk spine service, the Neurospinal Disorders Program, and the UCSF Spine Center. He is board certified in neurosurgery. He was named to the 2015-2019 Top Doctors lists in San Francisco Magazine, and among America’s Top Doctors for both neurosurgery and cancer from 2010 to 2019. His tumor practice focuses on en bloc tumor resection for chordoma, chondrosarcoma, giant cell tumor, soft tissue sarcoma, sacral tumors, and other primary and metastatic tumors. While at UCSF, Dr Ames developed and published the transpedicular approach to previously unresectable cervical and cervical thoracic tumors. He serves as Spine Section Lead editor for Operative Neurosurgery. 

Dr Ames serves as the UCSF site director for the International Spinal Deformity Study Group and the AO Scoli-Risk Study. He also directs the neurosurgical spinal deformity service, which performs over 200 cases per year for correction of scoliosis, kyphosis, flat back, and chin-on-chest deformity in ankylosing spondylitis. His research work in spinal deformity has won the prestigious Hibbs award, as well as the Moe award, the Goldstein award, and Whitecloud awards from the Scoliosis Research Society. Dr Ames developed and published the first ever classification for cervical spine deformity and cervical osteotomy with the international spine study group.  He is known for developing many innovative concepts to allow safer treatment planning and risk characterization for complex spine surgery such as the adult deformity frailty index, the adult deformity invasiveness index and co-founding and directing the nonprofit research group Global Spine Analytics which has pioneered the use of Artificial Intelligence Decision Support Tools for Adult Scoliosis and Deformity Surgery.  In 2019, Dr Ames published the first Machine Learning based Adult Scoliosis Classification. 

Dr Ames is internationally recognized for his work in spine tumor, deformity, scoliosis and cervical kyphosis and has published over 400 peer-reviewed publications. He has been the honored international guest lecturer for the Australian Spine Society, the Argentine Spine Society, Berlin Spine Society, Brazilian Spine Society, the Japanese Orthopedic Association, the Japanese Neurosurgical Society, the Korean Spine Society, and the Asian Pacific Spine Society. He has served as chairman for over 100 national and international courses to teach advanced tumor and deformity techniques to neurosurgeons and orthopedic surgeons around the world and has been a visiting professor at the Hospital for Special Surgery, UCLA, and Massachusetts General Hospital.

Dr Ames receives royalties from Stryker, Biomet Zimmer Spine, DePuy Synthes, Nuvasive, Next Orthosurgical, K2M and Medicrea. He is a consultant for DePuy Synthes, Medtronic, Stryker, Medicrea, K2M, Biomet Zimmer, and conducts research for Titan Spine, DePuy Synthes and ISSG. He receives grant funding from SRS, is the Director of Global Spine Analytics and is on the Executive Committee of ISSG.

ORCiD: 0000-0003-2618-3098


Dr Kenan Arnautović, MD, PhD, FAANS, FACS

Dr Kenan Arnautović, MD, PhD, FAANS, FACS, is a Professor of Neurosurgery at the Semmes-Murphey Clinic and the Department of Neurosurgery, University of Tennessee, Memphis, TN. He also holds teaching appointments at the Sarajevo School of Medicine, Bosnia-Herzegovina, and at the Department of Neurosurgery, JJS University in Osijek, Croatia. He specializes in skull base neurosurgery, brain and spinal cord tumor microsurgery, and general neurosurgery.

He has completed two residencies in neurosurgery. The first one was at the Department of Neurosurgery, University Clinical Center, Sarajevo, Bosnia-Herzegovina. The second res idency was at the Department of Neurosurgery, University of Arkansas for Medical Sciences, Little Rock, Arkansas, under Professors Sam Al-Mefty, Gazi Yasargil, Glenn Pait, Rick Boop, Ali Krisht, and Charles Teo. He also completed skull base fellowship there, mentored by Dr Al-Mefty.

Dr Arnautović has published extensively in peer-reviewed neurosurgery journals, including 3 front covers of the Journal of Neurosurgery. He has delivered many invited lectures throughout the world and has mentored numerous international neurosurgeons. For many years, he has been teaching faculty at Dr Al-Mefty's and Dr Krisht's skull base courses.

Dr Arnautović is co-founder and Past President of the Bosnian-Herzegovinian-American Academy of Arts and Sciences (BHAAAS). He is a member of the Tennessee Neurosurgical Association, the Southern Neurosurgical Society, the American Association of Neurological Surgeons, the Congress of Neurological Surgeons, the North American Skull Base Society, the North American Spine Society, and the Croatian Neurosurgical Society, and is an honorary member of the Association of Neurological Surgeons in Bosnia-Herzegovina and the South Eastern European Neurosurgical Society (SEENS).

Dr Arnautović currently serves as a Chairman, International Programs Committee of the American Association of Neurosurgeons (AANS), a Second Vice-President of World Federation of Neurosurgical Societies (WFNS) and Chairman, North American Chapter, South-East European Neurosurgical Society (SEENS).

Dr Arnautović has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.

ORCiD: 0000-0003-3745-288X


Dr Mark Bain

Dr Mark Bain is very involved in the care of patients through his cerebrovascular and endovascular neurosurgical practice at The Cleveland Clinic. He has significant interest in developing and perfecting assessments, evaluations, interventions, and outcomes for safe and efficacious hemorrhagic interventions.

Dr Bain's practice is 100% endovascular and cerebrovascular hemorrhagic neurosurgery, with research and resident/fellow education components included. His involvement in outpatient clinic, inpatient service, acute stroke, and/or hemorrhagic response teams provides appropriate interaction with patients and families, enabling the advancement of research in the field through patient recruitment/enrollment, analysis, outcomes, and quality measures.

Dr Bain is committed to and interested in generating and reviewing unbiased data in order to improve stroke care and outcomes.

ORCiD: 0000-0002-0883-5796


Matias Baldoncini, MD

Matias Baldoncini, MD, was born in Cordoba province, Argentina, in 1985. He completed his medical education at the National University of Rosario, School of Medicine in 2010. He was trained at the Department of Neurosurgery Vicente Lopez y Planes Hospital, Buenos Aires and finished his residency program in 2017.

Later, he continued with his training in microsurgical neuroanatomy at the Beneficencia Portuguesa Hospital in São Paulo, led by Prof. Evandro de Oliveira. He completed his training at Harvard Medical School, at the Skull Base Department Brigham and Women's Hospital in Boston city, under the supervision of Prof. Ossama Al-Mefty.

He currently works as Resident Instructor at the San Fernando Hospital and Vice-Director of the Laboratory of Microsurgical Neuroanatomy, Second Chair of Gross Anatomy, School of Medicine, University of Buenos Aires.

Dr Matias Baldoncini is member of the Neurosurgical Anatomy Committee of the World Federation of Neurosurgical Societies WFNS.

Dr Baldoncini's main area of ​​interest is surgery of skull base tumors, brain aneurysms and cerebral arterio-venous malformations and he has developed in recent years in minimally invasive surgery "Key Hole".

He has authored 2 books, book chapters, more than 45 publications and 12 publications indexed in Pubmed.

Together with Argentinian colleagues they have developed and published a 3D system to perform three-dimensional neurosurgeries, being pioneers in South America, forming part of an International group of neurosurgeons called 3dneuroanatomy. Being the organizer of hands-on courses based on dissections and 3D surgical videos in Argentina and other countries.

Dr Baldoncini has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.

ORCiD 0000-0001-9323-8306


Dr Mustafa K. Baskaya

Dr Mustafa K. Baskaya is the Director of the Skull Base Surgery Program at University of Wisconsin Hospital and an Associate Professor at the UW School of Medicine and Public Health. Dr Baskaya completed his neurosurgical training at the Ankara University School of Medicine, Turkey, and University of Miami Medical School, Miami, FL. He also completed fellowships in neurovascular and skull base surgeries at Nagoya University, Japan, and Louisiana State University. He has a strong and diverse background in both research and clinical care. He specializes in skull base and cerebrovascular surgery. His neuroanatomical research interests include microsurgical and microvascular techniques and finding the safest pathways for vascular lesions (brain aneurysm and AVMs) and brain tumors. Additionally, he maintains a laboratory that focusses on the use of stem cell therapy to enhance neuroprotective processes following focal cerebral ischemia. He has published more than 150 manuscripts and serves as editorial board member in prominent neurosurgical journals. D. Baskaya's national and international leadership roles include the World Federation of Neurosurgical Societies Skull Base Committee, AANS/CNS Joint Section of Cerebrovascular Surgery Executive Committee, AANS/CNS Joint Section of Cerebrovascular Surgery Subcommittee for Cerebrovascular Research Award, and the Congress of Neurological Surgeons' Educational Division and International Division.

Dr Baskaya has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.


David F. Bauer, MD, MPH

David F. Bauer, MD, MPH, is Associate Professor of Surgery and Pediatrics at Baylor College of Medicine / Texas Children’s Hospital in Houston, Texas. He is a graduate of Johns Hopkins University and the University of Michigan Medical School. He completed internship and residency at University of Alabama at Birmingham, followed by fellowship in pediatric neurosurgery at University of Washington / Seattle Children’s Hospital. As a former Assistant Professor of Surgery and Pediatrics at Dartmouth-Hitchcock Medical Center, he was director of pediatric neurosurgery. While at Dartmouth, he completed a Masters in Public Health at the Geisel School of Medicine at Dartmouth in 2019. After transitioning to Houston, he is currently the co-director of craniofacial surgery at Texas Children’s Hospital with a second focused practice in the treatment of complex pediatric spine and spinal cord tumors and complex pediatric spine deformity. He is chair of the national guidelines committee for the Pediatric Section of the AANS/CNS, and he serves on the CNS Guidelines committee and the AANS/CNS Joint Guidelines Review Committee. He has helped with the production and review of guidelines in multiple organizations including PALSI, AES, AAP, AAN, CNS, and AANS. He is an active member of the AAP, ASPN, ACS, CNS, and AANS. SCOPUS Author ID: 2988567

Disclosures: Dr Bauer has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.

ORCiD: 0000-0003-3548-0887


Dr Emine Bayman

Dr Emine Bayman is an associate professor of Biostatistics at The University of Iowa, where she is the Deputy Director of the Clinical Trials Statistical and Data Management Center (CTSDMC). She also holds a secondary appointment at the Department of Anesthesia, University of Iowa where she has worked for more than 10 years as a faculty.

Dr Bayman has a PhD in Biostatistics from the University of Iowa with research interests in Bayesian statistics, design of multi-center clinical trials, and prediction models of post-surgical chronic pain.

Dr Bayman has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.

ORCiD: 0000-0003-2615-0915


Matthew Bender

Matthew Bender is an Assistant Professor of Neurosurgery in the Division of Stroke and Cerebrovascular Disease at the University of Rochester in Rochester, NY. He grew up in Hamburg, NY before studying Philosophy as an undergraduate at Yale and attending medical school at Johns Hopkins. Dr Bender completed Neurological Surgery residency and a two-year enfolded Endovascular Neurosurgery fellowship at the Johns Hopkins Hospital. His research and writing has been focused on cerebral aneurysms, subarachnoid hemorrhage, flow diversion technology, and antiplatelet therapy. Outside work, he is an avid runner and triathlete. 


Dr Bernard Bendok

Dr Bernard Bendok is currently Professor of Neurological Surgery, Otolaryngology and Radiology as well as the Director of the Skull Base Vascular Neurosurgery, Neurointerventional Surgery and Neurovascular Radiosurgery programs at Northwestern University’s Feinberg School of Medicine and Northwestern Memorial Hospital in Chicago as well as the Surgical Co-director of the Neurological ICU.

Dr Bendok graduated from Northwestern University’s Feinberg School of Medicine and completed his neurosurgical training at Northwestern Memorial Hospital with a focus on microsurgical approaches to neurovascular and skull base pathologies. He received the AANS/CNS Mullan Neuroendovascular Fellowship Award and completed a Neuroendovascular Surgery fellowship at the State University of New York at Buffalo with the internationally acclaimed endovascular pioneer Dr L. Nelson Hopkins. Dr Bendok then spent a decade working with the internationally renowned vascular neurosurgeon H. Hunt Batjer, focusing on the microsurgical treatment of complex neurovascular and cranial base diseases.

Dr Bendok’s clinical practice is currently focused on the microsurgical, interventional and radiosurgical management of neurovascular and skull base pathologies. His research has focused on clinical trials and innovations in vascular and skull base neurosurgery. His educational efforts have been focused on multimedia approaches to neurosurgical education and simulation training. He is currently working with national neurosurgical organizations to develop a validated simulation curriculum for neurosurgery residents.

Dr Bendok has published over 200 peer-reviewed papers and 50 chapters, and is a member of Alpha Omega Alpha. Dr Bendok serves on the executive committees of the Congress of Neurological Surgeons and the Cerebrovascular Section of the AANS and CNS. He directs the educational committees for both organizations. Dr Bendok has given over 175 national and international invited presentations and has co-edited three textbooks and one journal supplement. His research has been funded by the Eleanor Wood-Prince Grant Initiative, the Erika Keeney Foundation, the Blue Bird Foundation, the Brain Aneurysm Foundation, and the NIH.

Dr Bendok receives research funding from Microvention.

ORCiD: 0000-0002-3506-3074


Dr Shay Bess

Dr Shay Bess is a spine surgeon in Denver, Colorado at Denver International Spine Center specializing in scoliosis, cervical and thoracolumbar spine deformity, and revision spine surgery in pediatric and adult patients. Dr Bess received his undergraduate degree from Columbia University in New York City, his medical doctorate from The Johns Hopkins University School of Medicine, completed his orthopedic surgery residency at Case Western Reserve University in Cleveland, Ohio and completed a fellowship in pediatric and adult spinal surgery at the Washington University in St. Louis.

Dr Bess is the president and founder of the International Spine Study Group Foundation which is a multi-center non-for-profit research foundation that studies clinical and economic outcomes and best practice guidelines for adult patients with spine deformity conditions. Since the inception in 2009, the International Spine Study Group has presented over 2000 scientific abstracts, has published over 300 peer reviewed manuscripts, and is currently the most productive spine research study group in the world. Dr Bess has been recognized as Colorado Magazine Best Orthopedic Surgeons from 2018-2020 and is engaged in several committee and leadership efforts for multiple societies including the Scoliosis Research Society and North American Spine Society, and serves on the spine advisory board for Hospital Corporation of America and for the Health Trust Group Purchasing Organization, and serves on the medical and scientific board for the National Spine Health Foundation, and the editorial review board for Spine Deformity Journal and Spine Journal. Dr Bess has over 350 manuscript publications and is an internationally recognized leader as a spine surgeon and researcher. In addition to his research and clinic efforts, Dr Bess has participated in medical mission work for charity efforts that provide spine care for children in Ethiopia, Ghana, and Colombia.

Dr Bess is a consultant and receives royalties from K2M Stryker, receives royalties from Nuvasive, and receives research funding in conjunction with the International Spine Study Group from DePuy Synthes, Medtronic, Globus, SI Bone, K2M Stryker, SeaSpine, Orthofix, and Nuvasive.

ORCiD: 0000-0002-9697-8999


Dr Deb A. Bhowmick

Dr Deb A. Bhowmick is a neurosurgeon specializing in complex spinal surgery. He is an Assistant Professor and Section Co-Chief of Spinal Neurosurgery in the Department of Neurosurgery at the University of North Carolina at Chapel Hill. He completed a fellowship in spinal surgery at the Cleveland Clinic. His clinical interests include treatment of spinal tumors, spinal trauma, rheumatologic diseases of the spine, complex spinal deformities, and minimally invasive treatment of spinal degenerative conditions. Dr Bhowmick specializes in the endoscopic treatment of basilar invagination and other disorders of the craniocervical junction. His research efforts concentrate on the epidemiology and comparative effectiveness of various treatments for spine fractures in the elderly.

Dr Bhowmick has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.


Dr John A Boockvar

Dr John A Boockvar is the Vice Chair of the Department of Neurosurgery at Lenox Hill Hospital and Director of the Brain Tumor Center, and the Pituitary/Neuroendocrine Center of the Department of Neurosurgery and the New York Head and Neck Institute at Lenox Hill and Manhattan Eye, Ear and Throat Hospitals. Dr Boockvar is a Professor of Neurological Surgery and Otolaryngology/Head and Neck Surgery at the Zucker School of Medicine. Dr Boockvar is an investigator at the Feinstein Institutes for Medical Research where he directs the Laboratory for Brain Tumor Biology and Therapy.

Dr Boockvar is internationally known for his surgical expertise and for providing patients with safe, effective, and minimally invasive treatment for brain tumors, skull base disorders, and disorders of the spine. Dr Boockvar's surgical expertise is in benign and malignant brain tumors, skull base and endoscopic pituitary surgery, spinal and peripheral nerve tumors, minimally invasive spinal surgery, and complex spinal disorders. Dr Boockvar has been recognized for his novel research in brain tumors and stem cell biology. Dr Boockvar has been repeatedly named to the lists of New York Magazine’s Top Docs, Best Doctors in New York-Castle Connolly, New York SuperDoctors, America's Top Surgeons, America's Best Doctors, and America's Best Doctors for Cancer. His research has been widely published and he has received numerous national awards including the Eric Lichtenstein Humanitarian Award from Voices Against Brain Cancer for his compassionate work in treating patients with brain cancer. In 2016 Dr Boockvar was elected to the prestigious Academy of Neurological Surgeons. In 2017 he was elected to the Senior Society of the American Board of Neurological Surgery.

Dr Boockvar currently co-directs the Laboratory for Brain Tumor Biology and Therapy at the Feinstein Institutes for Medical Research. His laboratory interests have focused on adult human neural stem cell biology as it relates to brain tumor formation and resistance to therapy. Dr Boockvar is a world expert on blood brain barrier disruption to improve the delivery of therapeutics to the human brain. Dr Boockvar is the principal investigator of several cutting edge clinical trials using blood brain barrier disruption to deliver high dose chemotherapy for patients with malignant brain tumors that have been featured in the New York Times and Wall Street Journal. Dr Boockvar has served as Editor-in-Chief of the journal Current Stem Cell Research and Therapy and is an editorial board member of the Journal of Neuro-Oncology, Neurosurgery, Journal of Neurosurgery, and Recent Patents on Anti-Cancer Drug Discovery. Dr Boockvar directs the Brain Tumor Biotech Center at the Institute that seeks to bridge the translational gap between basic and clinical science for patients with malignant brain tumors. Dr Boockvar's laboratory has been funded by the National Institutes of Health and he was recently awarded the American Association of Neurological Surgeons Pinnacle Partners Award for his research into brain tumors. He has also won research awards from Voices Against Brain Cancer, the American Brain Tumor Association, the Starr Foundation, Anspach Companies, and the Adelson Foundation.

Dr Boockvar has been featured on special episodes of the Dr Oz Show on brain tumors and Medical Mysteries, Good Morning America and the Today Show with Megyn Kelly. Dr Boockvar is also an honorary surgeon of the NYPD and the New York State Troopers.

Dr Boockvar has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.


Dr Ketan R. Bulsara

Dr Ketan R. Bulsara is a Professor and Chief of Neurosurgery, Program Director of Neurosurgery Residency and Director of Operating Room Quality at the University of Connecticut/UConn Health.

He is a board-certified neurosurgeon and is one of only a select few neurosurgeons in the country who is dual fellowship trained in skull base/cerebrovascular microsurgery and endovascular neurosurgery. He has won numerous awards from the American Association of Neurological Surgeons and the Congress of Neurological Surgeons. Dr Bulsara has consistently been listed as one of the top physicians and surgeons in the United States by the Consumer Research Group of America based in Washington, DC. Prior to his appointment at Yale, he directed the Walter Dandy Neurosurgical Intensive Care unit and served as the Director of Skull Base and Cerebrovascular Neurosurgery at the University of Missouri–Columbia. At Yale, he served as Director of Skull Base and Neuroendovascular surgery, building successful programs prior to being recruited as Chief of Neurosurgery for the University of Connecticut.

Dr Bulsara has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.


Ollie Burton

Ollie Burton is a third-year graduate entry medical student at the University of Warwick and current Co-President of its Surgical Society, previously completing a degree in Cellular & Molecular Biology. He is an aspiring academic neurosurgeon with particular interests in medical education and widening participation in medicine.

Ollie Burton has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.

ORCiD: 0000-0003-3569-069X


Richard William Byrne

Richard William Byrne was born in Chicago on January 25th, 1965. He attended the University of Illinois for undergraduate studies in biology, graduating Phi Beta Kappa. He attended Northwestern University Medical School, graduating in 1991. He completed residency training at Rush University Medical Center where he remained as faculty after additional training in brain tumor and epilepsy surgery. In 2005, Dr Byrne became acting Chairman of the Department of Neurosurgery at Rush and in 2007, became Professor and Chairman of the Department. He also served as Residency Program Director from 2006-2009. In 2013 he was named the Roger C. Bone, MD, Presidential Professor of Rush University.

Dr Byrne is a board-certified neurosurgeon who specializes in brain tumor surgery, surgical treatment for epilepsy, skull base surgery, pituitary surgery, trigeminal neuralgia, and radiosurgery. He is actively involved in a number of epilepsy and brain tumor surgery trials, basic science research in epiloptogenesis, and brain tumor genetics, and has authored more than 100 publications and book chapters on these subjects.

Dr Byrne has served a leadership role in numerous professional societies. He has served as President of the Rush Surgical Society, President of the Chicago Neurological Society, President of the Illinois State Neurosurgical Society, Chairman of the Board of Directors of the Interurban Neurosurgical Society, member of the FDA Neurological Devices Panel, National Course Director of the Society of Neurological Surgeons resident courses, member of the Executive Committee of the Congress of Neurological Surgeons, and Treasurer of the Neurosurgical Society of America.


Bo Cai

Bo Cai, PhD, is tenured Professor of Biostatistics in Department of Epidemiology and Biostatistics at University of South Carolina. His research focuses on developing more efficient and robust methods for analyzing various data. Dr Cai is the PI and co-investigator on multiple extramural projects funded by NSF, NIH, and CDC. So far he has over 100 peer-reviewed publications. Dr Cai is an editorial board member of several journals. He is an elected member of International Statistical Institute (ISI).

Dr Cai has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.


Dr. Andrew Carlson

Dr Carlson is an Assistant Professor of Neurosurgery at the University of New Mexico, the Department Director of Research, and the Surgical Director of the UNM Comprehensive Stroke Center. Research interests include cerebral physiology after brain injuries including subarachnoid hemorrhage, stroke, and traumatic brain injury with a particular interest in the emerging field of Spreading Depolarization physiology. In addition, he has interest in cerebrovascular and complex cranial approaches and techniques and research methodology with over 70 peer reviewed publications. He is an active member and alternate chair for the UNM Institutional Review Board. He has received NIH and DOD funding for clinical trial research and is nationally involved in multiple randomized trials. He serves on the JNS Editorial Board, the AANS/CNS Joint Guidelines Committee, the ABPN Neurocritical Care Examination Committee, and the ABNS Neurocritical Care Examination Committee. As a Methodology reviewer, Dr Carlson has a Master’s Degree in clinical research. In addition, he has extensive experience in Evidence-based Medicine, Guidelines review, and systematic review methodology. He has been involved in design and steering committees for several international clinical trials including MISTIE, NEWTON, and ENCASE.

Disclosures: Dr Carlson is a shareholder for Cerebroscope and has received research funding from NIH/NIGMS, UNM Clinical Translational Science Center, UNM Center for Brain Recovery and Repair, LANL, IRRAS, Polyganics, and Edge Therapeutics.

ORCiD: 0000-0003-2189-3699


Michael Chan

Michael Chan, MD, is an Associate Professor of Radiation Oncology at the Wake Forest School of Medicine where he specializes in treatment of patients with primary brain tumors and brain metastases. He is the Co-Director of the Gamma Knife Program at Wake Forest, and also serves as the residency director for the Department of Radiation Oncology.

Dr Chan’s research focuses on modeling of brain metastasis behavior and patterns of failure, radiation-induced cognitive decline, and the use of genomics to guide radiation oncology-based decision-making for both primary and metastatic brain tumors. His research has led to over 70 peer-reviewed manuscripts and book chapters.

Dr Chan received his MD degree from NYU School of Medicine and completed his Radiation Oncology residency training at Tufts Medical Center. He serves as an Associate Editor on the Radiation Oncology Section of Neurosurgery, the official journal of the Congress of Neurological Surgeons.

Dr Chan has served as a consultant for Monteris Medical. He also receives an honorarium from Elekta for giving a course on intracranial applications of stereotactic radiotherapy.


Dr Joshua Chern

Dr Joshua Chern completed his neurosurgery residency at Baylor College of Medicine, Houston, TX, and has completed pediatric neurosurgery fellowships at Birmingham, AL. He currently practices at Children's Healthcare of Atlanta and is a clinical professor at the Department of Neurosurgery, Emory University. He serves as Director of Quality of Care for Neuroscience and as Epilepsy Surgery Director at Children's.

Besides clinical work, Dr Chern is involved with resident education and research. His academic interests include health services delivery and outcome measures. He has more than 80 peer-reviewed articles and book chapters.

Dr Chern has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.


Dr Michael Chicoine

Dr Michael Chicoine is a practicing neurosurgeon and holds the August Busch Jr. Professorship in Neurological Surgery at Washington University School of Medicine in St. Louis where he has been a faculty member since 1998.  He completed his Bachelor of Science at the University of Illinois in Champaign-Urbana, and his MD at UCLA in Los Angeles.  He completed neurosurgery residency training under Dr Ralph Dacey, Jr. at Washington University and Barnes-Jewish Hospital in St. Louis, and fellowship training in skull base neurosurgery at the University of Cincinnati with Dr Harry van Loveren.  He treats patients with a variety of brain, pituitary and skull base tumors and cerebrovascular disorders using traditional transcranial approaches, endonasal endoscopic approaches, “minimally invasive” techniques, and stereotactic radiosurgery. Dr Chicoine’s research efforts have been in the areas brain tumor biology, and clinical outcomes investigations in the areas of skull base surgery, brain tumors and cerebrovascular disease. One of his many areas of interest is the application of intraoperative MRI to the surgical management of skull base and other brain tumors.

Dr Chicoine’s disclosures are as follows: IMRIS, Inc. – Unrestricted educational grant to support research nurse and database for assessment of outcomes for patients undergoing surgery with iMRI: IMRIS Multi-Center IMRI Neurosurgery Database (I-MiND) The Head for the Cure Foundation – charitable funding source to support brain tumor research. Mrs. Carol Rossfeld and The Alex & Alice Aboussie Family Charitable Foundation, a charitable funding source to support brain tumor research. He is the site principal investigator for recently completed multicenter clinical trial: Minimally Invasive Surgery Plus rt-PA for Intracerebral Hemorrhage Evacuation (MISTIE III). He is also the site principal investigator for ongoing multicenter clinical trial: Early MiNimally-invasive Removal of IntraCerebral Hemorrhage (ICH) (ENRICH).


Rohan Chitale

Rohan Chitale, MD, is an Assistant Professor of Neurological Surgery at Vanderbilt University Medical Center, with a specialty in open cerebrovascular and endovascular neurosurgery.  Dr Chitale received his undergraduate degree from the University of Pennsylvania where he graduated magna cum laude. He received his medical degree from Jefferson Medical College in Philadelphia, PA and is a member of Alpha Omega Alpha.  He completed his neurological surgery residency and endovascular neurological surgery fellowship at Thomas Jefferson University Hospital in Philadelphia. 

His academic interests focus on applications of engineering in medicine, clinical outcomes research, simulator training, and resident education. He has served as an investigator for multiple national clinical trials and registries.  He currently serves as Associate Residency Program Director for the Vanderbilt Neurosurgery Residency Program.  His areas of clinical interest include aneurysms, arteriovenous malformations, stroke, intracerebral hemorrhage, and other neurovascular disorders of the brain and spine.

Dr Chitale receives research grants from Medtronic and Cerenovus, financial support from NFL, and currently also serves as a member of DSMB for INVEST trial.

ORCiD: 0000-0001-8591-8854


William Curry

William Curry is the Director of Neurosurgical Oncology at Massachusetts General Hospital and an Associate Professor of Neurosurgery at Harvard Medical School. His surgical practice focuses on the management of neoplasms of or in the central nervous system, with a particular emphasis on cranial base lesions. He is proficient in endoscopic and open techniques for the treatment of benign and malignant tumors, and he is a valued instructor at regional and national operative courses. In addition, Dr Curry is involved in investigation in neuro-oncology – he is the Director of the Translational Brain Tumor Immunotherapy Laboratory at Massachusetts General Hospital.

Dr Curry graduated from Cornell University Medical College in 1997. He was a surgical intern and a resident in neurosurgery at Massachusetts General Hospital from 1997–2003, at which time he chose to stay, accepting a faculty position in their Brain Tumor Center.

Dr Curry has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.

ORCiD: 0000-0002-8036-1847


Dr Sunit Das

Dr Sunit Das is a neurosurgeon and scientist at St Michael's Hospital and the Keenan Research Centre, and assistant professor in the Department of Surgery at the University of Toronto. Dr Das studied English literature at the University of Michigan and philosophy at Harvard University before moving to Chicago for medical school at Northwestern University. He completed a PhD at the National Institutes of Health, where he studied the molecular processes that underlie adult neurogenesis in the lab of Dr ZuHang Sheng. He returned to Chicago for his neurosurgical residency, during which time he also began work on cancer stem cells in primary brain tumors in the lab of Dr John Kessler. He was recruited to the University of Toronto in 2010. Dr Das's clinical practice and clinical research focus of the treatment of patients with tumors of the brain and spine. His laboratory at the Hospital for Sick Children focuses on non-coding RNA and control of cell identity in glioblastoma and neural stem cells. He is a member of the Arthur and Sonia Labatt Brain Tumour Research Centre at the Hospital for Sick Children and is faculty with the Institute of Medical Science and Department of Laboratory Medicine and Pathobiology.

Dr Das is a paid consultant for Abbvie Corporation and Guidepoint Medical. He is also a member of the scientific board of the Subcortical Surgery Group, and on the speakers' bureau for NICO Medical.

ORCiD: 0000-0002-2146-4168


Dr Carlos A. David

Dr Carlos A. David obtained his Bachelor of Science in Biochemistry at the University of Miami in 1986. He then attended the University of Miami Miller School of Medicine, where he completed his medical degree with research distinction and achieved AOA status in 1990. After finishing his internship in general surgery at Jackson Memorial Hospital, he underwent residency training in neurological surgery at Jackson Memorial Hospital from 1991 through 1996. Following the conclusion of his residency, Dr David completed an 18-month cerebrovascular and skull base surgery fellowship under Dr Robert F. Spetzler at the Barrow Neurological Institute.

In 1998, Dr David joined the faculty of the University of Missouri Department of Neurosurgery, where he served as director of cerebrovascular surgery, chief of the VA hospital neurosurgery section, and co-director of the Neuro-Medical ICU at the University Hospital. In 2000, Dr David relocated to the Boston area, joining the Department of Neurosurgery at the Lahey Clinic Medical Center. He is currently the associate program director for Tufts University's neurosurgery residency and serves as director of cerebrovascular and skull base surgery at the Lahey Clinic. He is an associate professor of neurosurgery at Tufts University School of Medicine and is actively involved in education of medical students.

Dr David currently serves on the executive committee of the AANS/CNS Joint Cerebrovascular Section as Vice Chairman. He also serves on the North American Skull Base Society Executive Committee as Director at Large, Chair of the Website Committee, and co-director of the pre-meeting course. He has published extensively and is currently involved as PI for an international registry on EC-IC Bypass.

Dr David's major areas of clinical and research interest are brain aneurysms, subarachnoid hemorrhage, arteriovenous malformations (AVMs), cavernous malformations, carotid artery stenosis, and revascularization. Other areas include endoscopic skull base surgery, pituitary tumors, acoustic neuromas, and skull base meningiomas.

Dr David owns personal stock in Kogent Surgical, Elum Technologies and NextGen Biologics


Jeffery Dawson

Jeffery Dawsonreceived his academic degrees from Brigham Young University and Harvard University, and is a Professor of Biostatistics at the University of Iowa College of Public Health (CPH).  He has served as Director of Graduate Studies in Biostatistics, a Faculty Senate member, a member of the Institutional Review Board, and the chair of the CPH Faculty Council. He has collaborated with over 20 departments in the health sciences, and is particularly known for his research in elderly and neurologically impaired drivers, as well as in cardiovascular research. His methodological interests include longitudinal data, time series data, and clinical trials. His outreach activities include educational, research, and public health efforts in Haiti, Mexico, and the Dominican Republic.  He has served as the CPH Associate Dean for Faculty Affairs since 2011.

Dr Dawson has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.

ORCiD: 0000-0003-2709-0360


Amir Dehdashti, MD, FACS

Amir Dehdashti, MD, FACS is the director of cerebrovascular neurosurgery research at North Shore University Hospital and associate professor of neurosurgery at Hofstra Northwell School of Medicine. Dr Dehdashti completed his neurosurgery training under Professor de Tribolet in Geneva, Switzerland, and is board certified in neurosurgery by both the Swiss Board and the Board of the European Association of Neurosurgical Societies. Dr Dehdashti completed fellowship training in both cerebrovascular and skull base surgery, including endoscopic skull base surgery, at the Toronto Western Hospital. He is one of the few dually trained cerebrovascular and skull base surgeons in the country with two dedicated and separate fellowships. Dr Dehdashti has significant clinical expertise in performing complex intracranial surgery including cerebral bypass procedure. Dr Dehdashti has published over 70 papers and has given more than 100 lectures at different national and international meetings on topics relevant to cerebrovascular, skull base tumors, pituitary tumors, and cranial nerve disorders, including trigeminal neuralgia. His clinical expertise includes cerebrovascular surgery (aneurysm, AVM, brainstem cavernous malformation, moyamoya disease, cerebral revascularization), carotid endarterectomy, minimally invasive surgery for aneurysms (mini craniotomy), minimally invasive endoscopic skull base surgery (pituitary and skull base tumors), surgery for cranial nerve disorders (trigeminal neuralgia, hemifacial spasm, glossopharyngeal neuralgia), skull base surgery, craniovertebral junction pathologies, and acoustic neuroma surgery. His basic science and laboratory research is focused on molecular biology of brain AVMs.

Dr Dehdashti has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.

ORCiD: 0000-0002-9320-3098


Eric M. Deshaies, MD, FAANS, FACS

Eric M. Deshaies, MD, FAANS, FACS is a physician-scientist trained in neurological surgery at Albany Medical Center (New York) under the direction of Dr A. John Popp. Subsequently, he completed dual-fellowship training, first in the subspecialties of cerebrovascular/skull base neurosurgery at the University of Miami (Florida) under the tutelage of Drs Roberto Heros and Jacques Morcos, then in endovascular neurosurgery at Albany Medical Center under the tutelage of Dr Alan S. Boulos.

After the completion of training, he joined the faculty of SUNY Upstate Medical University in Syracuse, New York, as assistant professor in the Departments of Neurosurgery and Neuroscience & Physiology. There, he rose to associate professor of neurosurgery, served as acting chairman of the Department of Neurosurgery, and held the positions of Director of the SUNY Upstate Neurovascular Institute, Director of Cerebrovascular, Endovascular, and Skull Base Neurosurgery, Director of the Neurovascular Basic Science Laboratory, and the Neurosurgery Residency Program Coordinator. He has served on many national committees within the American Association of Neurological Surgeons and the Congress of Neurological Surgeons, is a member of the Sigma Xi Scientific Research Society, and serves on a number of editorial boards.

Dr Deshaies has published numerous abstracts, book chapters, and scientific papers on subarachnoid hemorrhage and ischemic stroke and is chief editor of two books, most recently, theHandbook of Neuroendovascular Surgery. His clinical and basic sciences research focuses on cerebral vasospasm after aneurysm subarachnoid hemorrhage and neuroprotective mechanisms for ischemic stroke.

Dr Deshaies now serves as Medical Director of the Crouse Neuroscience Institute in Syracuse NY, Director of the Cerebrovascular, Endovascular, and Skull Base surgery programs, and Director of the Endovascular Neurosurgery Fellowship Program. Additionally, he is currently an adjunct professor in the Department of Biology and Neuroscience at Syracuse University. Dr Deshaies has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.


Dr Sanjay Dhall

Dr Sanjay Dhall is an associate professor of neurosurgery and the director of the Spinal Neurotrauma Program at San Francisco General Hospital. He specializes in complex spinal surgery for spinal trauma, degenerative disease, tumor, and spinal deformity.

Before joining the University of California, San Francisco to lead the Spinal Cord Injury Clinical Research program, Dr Dhall was the Chief of Neurosurgery for the Level 1 Trauma Center at Grady Memorial Hospital, Emory University School of Medicine.

Dr Dhall is board certified by the American Board of Neurological Surgery. He is a co-author on the widely utilized Guidelines for the Management of Acute Cervical Spine and Spinal Cord Injuries (published in 2013), as well the Guidelines for the Performance of Fusion Procedure for Degenerative Disease of the Lumbar Spine, published in 2014.

Dr Dhall's work on cervical spinal cord injury guidelines was recently recognized by the United States Congress, and he received a Letter of Recognition signed by Congressmen representing the home states of the authors. He has been a frequently invited guest on CNN and has given expert commentary on brain and spinal injury in the news.

Dr Dhall is a consultant for DePuy Synthes Spine and Globus Medical.


Luis Alberto Domitrović

Luis Alberto Domitrović was born and raised in Corrientes, Argentina where he obtained his medical degree. After that, he completed his Neurosurgery residency in the Hospital de Clinicas, University of Buenos Aires. In 2013, he moved to Spain where he did the Radiology residency. In 2018 he obtained the European Society of Neuroradiology-Diagnostic and Interventional (ESNR) diploma in Neuroradiology. He is currently working in Málaga (Spain) as a radiologist. He has clinical interest in Endovascular Neurosurgery and Neuroradiology. He is also interested in medical visual communication and education, making medical illustrations for books, papers and presentations. Outside the hospital, Luis passions largely revolve around playing piano, traveling and eating Vietnamese food.

ORCiD: 0000-0001-8015-3207


Dr Ian F. Dunn

Dr Ian F. Dunn is in the Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, where he is an associate professor and specializes in skull base surgery using open and endonasal techniques. He is a member of the Center for Skull Base and Pituitary Surgery and directs a laboratory in the study of the genetic drivers of skull base tumors. He trained in neurosurgery at the Brigham and Women's Hospital with Dr Edward Laws and then learned open skull base approaches with Dr Ossama Al-Mefty. Dr Dunn has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.


Bree Eaton, MD

Bree Eaton, MD, is a board cerBree Eatontified radiation oncologist in the Department of Radiation Oncology at Emory University School of Medicine in Atlanta, GA. Dr Eaton specializes in the use of proton therapy and the treatment of pediatric cancers as well as adult brain and spine tumors. Dr Eaton graduated suma cum laude from Denver University with a BS in Cognitive Neuroscience, and completed medical school at the Medical University of South Carolina. Dr Eaton completed her Radiation Oncology Residency at Emory University and then went on to complete a fellowship in Pediatric Proton Radiotherapy and Clinical Research at Massachusetts General Hospital/Harvard University Medical School in Boston, MA. Dr Eaton has been extensively involved in clinical research evaluating the use of radiotherapy in pediatric and adult malignancies. She serves on the NRG Oncology Patient Centered Outcomes Research Committee and is a member of the American Society of Therapeutic Radiation Oncology and the American Society of Clinical Oncology.

Dr Eaton has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.


Tarek El Ahmadieh

Tarek El Ahmadieh MD is originally from Lebanon and completed his medical training at the Beirut Arab University. After finishing his surgical internship at the American University of Beirut, he moved to Chicago, Illinois and spent 3 years as a post-doctoral research fellow at the Northwestern University Feinberg School of Medicine under Dr Hunt Batjer and Dr Bernard Bendok. During this research fellowship, Dr El Ahmadieh was given the opportunity to take a leadership role in a multicenter, randomized, controlled clinical trial (HEAT) and worked on projects for the CNS which included simulation in neurosurgery. He helped develop the microanastomosis training module and the NOMAT score along with Dr Bernard Bendok and Dr Salah Aoun.

Dr El Ahmadieh moved to Dallas and is currently a neurosurgery resident at the University of Texas Southwestern Medical Center. In addition to his clinical responsibilities, Dr El Ahmadieh is interested in scholarly publishing. He and his resident colleagues introduced a reinvigorated focus on research within the program and organized quarterly meetings to plan, coordinate, and discuss resident research projects. Dr El Ahmadieh also serves as a reviewer for several neurosurgical journals.

Dr El Ahmadieh has special interest in brain and spinal tumors. He enjoys classical music and travel.


Najib El Tecle, MD

Najib El Tecle, MD, is a neurosurgery resident at St. Louis University Hospital in St. Louis, MO. He completed his medical studies at the Lebanese University, Faculty of Medical Sciences where he also studied computer science. He earned a Master’s in Biomedical Engineering from Northwestern University, McCormick School of Engineering and is currently completing a Master’s in Business Administration at the Johns Hopkins University, Carey Business School.

Dr El Tecle is a motivated and dedicated physician, he is interested in spine surgery and neurosurgical oncology. His research is focused on the use of artificial intelligence in robotic surgery and surgical robotics. Dr El Tecle is committed to education and has contributed to the neurosurgical field through numerous publications.

Dr El Tecle enjoys traveling with his wife Christine and his daughter Yara.

ORCiD: 0000-0002-5242-1646


Dr Christopher James Farrell

Dr Christopher James Farrell is an assistant professor of neurological surgery and a member of the Division of Neuro-Oncologic Neurosurgery and Stereotactic Radiosurgery at Thomas Jefferson University. His work is focused on the advancement of clinical outcomes for benign and malignant brain tumors, including minimally invasive surgical approaches and hearing preservation techniques for acoustic neuromas. He is an active member of the AANS/CNS Section on Tumors Executive Committee and Medical Advisory Board of the Hydrocephalus Association.

Dr Farrell performed his neurosurgical training at the Massachusetts General Hospital and completed a fellowship in skull base surgery at the University of Tennessee–Memphis.

Dr Farrell has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.


Dr Girish Fatterpekar

Dr Girish Fatterpekaris an associate professor of radiology and associate section chief of neuroradiology at NYU Langone Medical Center, New York. He did his medical school and radiology training at King Edward Memorial College in Mumbai, India and then moved to the United States. He completed his neuroradiology fellowship from Mount Sinai Medical Center, New York.

Dr Fatterpekar has received several research awards, including Cum Laude, Magna Cum Laude, and Summa Cum Laude awards from the ASNR and RSNA and the Norman E. Leeds award for the best scientific paper from ENRS. He has also received numerous teaching awards, including the Outstanding Teacher Award from Mount Sinai School of Medicine for 2008 and 2009 and the Attending of the Year for 2010. He has also received the Teacher of the Year Award from NYU Langone Medical Center for 2015.

His main areas of interest are brain tumor and temporal bone imaging. A well-known international speaker, his scholarly work includes more than 80 peer- and non-peer-reviewed articles as well as more than 30 invited articles and book chapters. He is also the author of 3 books and a reviewer for 7 journals.

Dr Fatterpekar has been the section editor for AJNR Case of the Week and Case of the Month, has served on the Education Program Committee of ASHNR, the Scientific Program Committee of ASNR, and has been the president of the Eastern Neuroradiological Society.

Dr Fatterpekar has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.


Dr Juan Fernandez-Miranda

Dr Juan Fernandez-Miranda is associate professor of neurological surgery at the University of Pittsburgh School of Medicine and associate director of the UPMC Center for Cranial Base Surgery. He is also director of the Surgical Neuroanatomy Lab and the NIH-funded Fiber Tractography Lab of the Department of Neurological Surgery at the University of Pittsburgh.

Dr Fernandez-Miranda completed neurological surgery residency at La Paz University Hospital in Madrid, Spain. From 2005 to 2007, he underwent fellowship training in microsurgical neuroanatomy at the University of Florida under Professor Albert L. Rhoton's mentorship. From 2007 to 2010 he continued subspecialty clinical training in cerebrovascular surgery at the University of Virginia and endoscopic endonasal and open skull base surgery at the University of Pittsburgh.

He has primary clinical interest and technical expertise in endoscopic skull base and pituitary surgery, open skull base surgery, and complex brain tumor surgery. He has performed over 1000 endoscopic endonasal operations for pituitary tumors and other skull base lesions such as craniopharyngiomas, meningiomas, and chordomas. He is highly regarded for his innovative contributions to the development and refinement of endoscopic endonasal skull base surgery and intrinsic brain tumor surgery.

Dr Fernandez-Miranda's Surgical Neuroanatomy Lab focuses on improving surgical techniques and outcomes by mastering knowledge of relevant surgical anatomy, following Professor Rhoton's example. His Fiber Tractography Lab is focused on the application of advanced fiber mapping techniques—High-Definition Fiber Tractography (HDFT)—for presurgical planning and intraoperative navigation to facilitate brain function preservation and improve resection rates in patients with complex brain lesions.

Several national and international awards have recognized his contributions. He has published extensively, with over 130 peer-reviewed publications, and he frequently lectures and teaches at national and international scientific meetings and professional courses.


Dr Manuel Ferreira

Dr Manuel Ferreira is the chief of Neurological Surgery Service at the University of Washington Medical Center, co-director of Skull Base and Minimally Invasive Neurosurgery, and a UW associate professor of neurological surgery. He is the surgical director of the UW Medicine Multi-Disciplinary Pituitary Program. He trained at the Massachusetts General Hospital in Boston, where he received specialized neurosurgical training in the treatment of neurofibromatosis and acoustic neuromas (vestibular schwannomas) with Dr Robert Martuza (the discoverer of the NF2 gene) and Dr Fred Barker. He is board-certified by the American Board of Neurological Surgery and fellowship-trained in the treatment of complex tumors of the brain and skull base. Dr Ferreira utilizes traditional open skull base approaches, minimally invasive endoscopic procedures, and gamma knife radiosurgery to provide a multifaceted approach to the tumor patient.

Dr Ferreira has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.


Dr David J. Fiorella

Dr David J. Fiorella has held appointments as an interventional neuroradiologist at the Cleveland Clinic and the Barrow Neurological Institute. He attended medical school at SUNY Buffalo, earning both MD and PhD (Neuropharmacology) degrees in 5 years, graduating summa cum laude. He completed a residency in radiology at Duke University Medical Center, where he was named chief resident in radiology, then completed diagnostic neuroradiology and endovascular neurosurgery fellowships at the Barrow Neurological Institute.

In 2005, Dr Fiorella performed the first 3 percutaneous transluminal angioplasty and stenting procedures for intracranial atherosclerosis with the Wingspan™ Stent System in North America. With a special FDA exemption for compassionate use of an unapproved device, he performed the first 3 aneurysm treatments using the Pipeline Embolization Device in North America, and was the first physician worldwide to perform intracranial angioplasty with the Sequent® Please Drug Eluting Balloon. He is one of the most experienced physicians in the world in the use of the Pipeline Embolization Device.

He joined the Stony Brook University Medical Center staff in June 2009 as professor of clinical neurosurgery and radiology. He has partnered with Henry H. Woo, MD, in the development of a world-class Cerebrovascular and Stroke Center at Stony Brook University Medical Center. Dr Fiorella has expertise in neuroendovascular treatment of cerebral aneurysms, endovascular management of acute stroke, embolization of CNS tumors, and endovascular treatment of cerebral arteriovenous malformations, spinal.

Dr Fiorella Consulting/Royalties/Research Support from: Penumbra, Sequent Medical, Microvention, Medtronic, Neurogami Medical, Codman, Marblehead Medical, Stryker, Simens Medical. Stocks/ownership in Vascular Simulations LLC, Marblehead Medical, Neurogami Medical.

ORCiD: 0000-0002-2677-8780


Paul A. Gardner, MD

Paul A. Gardner, MD, joined the faculty at the University of Pittsburgh Department of Neurological Surgery in 2008 after completing his residency and fellowship training at the University of Pittsburgh. He completed his undergraduate studies at Florida State University, majoring in biochemistry, and received his medical degree from the University of Pittsburgh School of Medicine.

Dr Gardner completed a 2-year fellowship in endoscopic endonasal pituitary and endoscopic and open skull base surgery. His research has focused on evaluating patient outcomes following these surgeries and, more recently, on genomic analysis of rare tumors. In April of 2008, Dr Gardner was named neurosurgical director of the Center for Minimally Invasive Cranial Base Surgery at the University of Pittsburgh Medical Center.

Dr Gardner is co-author of the book Skull Base Surgery, part of the Master Techniques in Otolaryngology—Head and Neck Surgery series published by Wolters Kluwer. The book offers step-by-step expert instruction on more than 45 procedures, covering both open and minimally invasive approaches to the skull base. Dr Gardner has authored 178 peer-reviewed publications and 67 book chapters.

Dr Gardner receives royalties from Peter Lazic US, Inc, has ownership interest in SPIWay, LLC , and has a Speaker agreement with Zeiss.


Dr Joseph J. Gemmete

Dr Joseph J. Gemmete received his medical degree from Wayne State University in 1993 and completed his diagnostic radiology residency at the Detroit Medical Center/Wayne State University in 1997. He then completed a neuroradiology fellowship at the Massachusetts General Hospital, followed by a neurointerventional surgery fellowship at the University of Michigan. In 1999 he joined the faculty at the University of Michigan as assistant professor. He was named a full professor in 2015 and currently is part of a multidisciplinary team at the University of Michigan treating cerebral vascular disease. His clinical practice focuses on the endovascular treatment of patients with aneurysms, arteriovenous malformations, and carotid stenosis, as well as cerebral hemorrhage and ischemia. He is the author of 118 peer-reviewed publications and is a reviewer as well as an associate editor for a number of journals. Dr Gemmete has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.


Dr Felicia C. Goldstein

Dr Felicia C. Goldstein is a Professor of Neurology (Neuropsychology Program) at Emory University School of Medicine. She received her PhD at Emory University and did postdoctoral fellowships at the Emory Center for Rehabilitation Medicine and the University of Texas Medical Branch in Galveston. Dr Goldstein is Board Certified in neuropsychology by the American Board of Professional Psychology/American Board of Clinical Neuropsychology, and is a Fellow of the American Psychological Association. She is a Member of the Scientific Merit Review Board of the VA Rehabilitation Research and Development Service’s TBI & Stroke Subcommittee, and has served as a Co-Investigator and Outcomes Co-Director of a NIH-sponsored multicenter clinical trial to determine the efficacy of Progesterone for acute traumatic brain injury. Dr Goldstein’s research focus involves cognitive disorders including memory and executive functioning that are associated with normal and pathological aging.

Dr Goldstein has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.


Jorge Gonzalez-Martinez

Jorge Gonzalez-Martinez completed medical school at the University of Sao Paulo, Brazil and training in neurosurgery at the Cleveland Clinic. In addition, Gonzalez finalized his post-graduation degree in neuroscience, obtaining his PhD degree in 2002, studying the sleep and awake cycle in the rodent limbic system. Following neurosurgical training, He began a clinical fellowship in Functional Neurosurgery and Epilepsy Surgery at the Cleveland Clinic. Subsequently, Gonzalez spent one additional year in France (University of Grenoble) training in invasive monitoring techniques for epilepsy. He became a staff member at the Epilepsy Center and Neurosurgery Department in 2008 when he returned from Europe, and focuses his clinical and academic activities on epilepsy surgery and neurosurgery. Currently, he is the director of the Epilepsy Surgery Fellowship Program (training more than 10 clinical fellows in recent years) and has held the Vice-Chairman for Surgical Operations position since 2014. He is also the research director for the surgical operations research program, mentoring residents and fellows from several surgical subspecialties in developing specific projects related to quality and safety. During the last 10 years, He published approximately 110 manuscripts, most of them related to epilepsy surgery and the neuroscience field. Gonzalez-Martinez also contributed extensively in medical education, teaching residents, fellows, and medical students for the last 8 years. He is the current epilepsy surgery fellowship program director at the Cleveland Clinic.

Dr Gonzalez -Martinez is a consultant for Zimmer Biomet.


J. Timothy Greenamyre

J. Timothy Greenamyre, MD, PhD, is the Love Family Professor and vice-chair of neurology, chief of Movement Disorders, and director of the Pittsburgh Institute for Neurodegenerative Diseases (PIND) and the American Parkinson Disease Association Advanced Center for Parkinson’s Disease Research at the University of Pittsburgh. He is a member of the Executive Advisory Board of the Michael J. Fox Foundation, and a member of the scientific advisory committee of the Parkinson’s Disease Foundation. He has been listed as one of the ‘Best Doctors in America’ since the mid-1990s. He is editor-in-chief of the scientific journal Neurobiology of Disease and of MedLink Neurology (www.medlink.com).

Dr Greenamyre has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.

ORCiD: 0000-0003-3468-7878


Dr Munish C. Gupta

Dr Munish C. Gupta is the Mildred B. Simon Distinguished Professor of Orthopaedic Surgery and Professor of Neurological Surgery at Washington University School of Medicine in St. Louis, Missouri. Dr Gupta specializes in spinal reconstructive surgery for both adults and children who need correction of spinal deformities resulting from scoliosis, kyphosis, spondylolisthesis and flatback syndrome. He has helped many patients to start living normally again, by correcting their spinal problems to regain lost mobility and to relieve pain and numbness. Dr Gupta is the PI of the Fox Study Group the largest database of 100° curves in pediatric deformity. He is also a member of the International Spine Study Group and Harms Study Group.

Gupta received his medical degree from Northwestern University in 1986 after completing a combined BA/MD honors program in medical education. After finishing an internship and residency at Northwestern, he completed a fellowship in spinal surgery in 1992 at the Norton Leatherman Spine Center, affiliated with the University of Louisville.

Following his fellowship, he became a clinical instructor at the University of California, Irvine, College of Medicine and also practiced at Rancho Los Amigos National Rehabilitation Center. In 1997, he joined the faculty at the University of California, Davis, and Shriners Hospital of Northern California where he built a surgical practice performing complex reconstructive surgery to correct pediatric and adult spinal deformities. While at UC Davis, he taught the treatment of complex spinal deformities to many national and international spine fellows. He also is experienced in cervical spinal surgery and the treatment of tumors and traumatic spine injuries.

Disclosures: DePuy-royalties, consultant, advisory, travel; Medtronic-consultant, travel; Globus-royalties, consultant, travel; Innomed-royalty; J&J-stock; Scoliosis Research Society-travel for faculty; AO Spine-honoraria, travel for faculty.

ORCiD: 0000-0002-4711-4377


William Hall, MD

William Hall, MD is a board-certified radiation oncologist with a passion for research in gastrointestinal malignancies and research in the radiological sciences. In the early portion of his career, he has devoted a considerable effort to understanding the role of advanced imaging modalities, including MRI, in radiation treatment planning specifically for pancreatic adenocarcinoma. Moreover, he has published several peer-reviewed articles devoted to the optimal use of radiation therapy for pancreatic adenocarcinoma. Such articles have related specifically to radiation therapy dose escalation and the optimal post-operative radiation therapy dosing strategy. In addition, he has conducted translational research into genomic predictors of outcomes in pancreatic adenocarcinoma. His future research goals are focused on improving radiation therapy delivery with MRI guidance using novel and unique MRI sequences that might enable precise delineation of the malignant portions of the pancreas and understand tumor response during treatment. He sees the next decade of research to be an exciting and transformative time in the management of pancreatic adenocarcinoma. Dr Hall receives Departmental Research Support from Elekta AB, Stockholm, Sweden.


Amgad Hanna

Amgad Hanna, MD grew up in Cairo, Egypt and graduated from the faculty of Medicine at Cairo University, in 1990. He completed Neurosurgery residency at the University of Rennes, in France, in 1999 and a Neurosurgery residency in the USA at Thomas Jefferson University hospital in Philadelphia. He further specialized in spine and nerves by completing a spine fellowship at Washington University in St. Louis, and a combined spine and nerve fellowship at Mayo Clinic, Rochester. In 2009, he joined the University of Wisconsin as an assistant professor of Neurosurgery.

He authored ‘Anatomy and Exposures of Spinal Nerves’, ‘Nerve Cases’, and ‘Neurosurgery Primary Examination Review’. He is also an editor of ‘Surgical Anatomy of the Lumbar Plexus’. Dr Hanna has a special interest in nerve anatomy. He defined the trifurcation of the upper trunk of the brachial plexus, the lateral femoral cutaneous nerve canal, and the types and variations of the palmar recurrent branch of the median nerve. He described the transposition of the lateral femoral cutaneous nerve as a novel treatment for meralgia paresthetica. He also holds US patent #D855,812 S for a doughnut-top hip pad designed to prevent meralgia paresthetica in the prone position. Dr Hanna has a basic science lab that studies spinal cord and nerve regeneration.


Dr Clement Hamani

Dr Clement Hamani's main field of expertise is stereotactic and functional neurosurgery. He is currently an associate professor of neurosurgery at the University of Toronto, a neurosurgeon at the Toronto Western Hospital, and a Research Associate at the Centre for Addiction and Mental Health (CAMH). His main research interests are in the field of the neurosurgical treatment of movement disorders, epilepsy, pain and psychiatric disorders.

Dr Hamani has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.


Dr Gregory Hawryluk

Dr Gregory Hawryluk is an Assistant Professor of Neurosurgery at the University of Manitoba where his practice is focused on the management of brain and spine trauma. Dr Hawryluk grew up in Sherwood Park, Alberta where he was designated as a Rutherford Scholar. He completed his medical school at the University of Alberta with Honors and Honors in Research in 2003. Thereafter he completed his neurosurgical residency at the University of Toronto. During this time he also completed a basic science PhD in Neural Repair and Regeneration under the supervision of Dr Michael Fehlings in which he examined the mechanism by which neural precursor cells augment recovery from spinal cord injury. Greg then went on to complete subspecialty training in the management of neurotrauma and complex spinal surgery at the University of California San Francisco under the supervision of Drs. Geoffrey Manley and Dean Chou.

Dr Hawryluk has recently returned to Canada after serving as the Director of Neurotrauma at the University of Utah. Dr Hawryluk is regularly invited to speak and to teach around the world and has contributed to a number of clinical practice guidelines which set the world standard for the management of traumatic brain and spinal cord injury. His laboratory investigations have explored a theory for what may cause chronic traumatic encephalopathy and he has published numerous manuscripts advancing the clinical management of neurotrauma. He has strong academic interests in advanced neuromonitoring, refinement of treatment thresholds, and clinical decision making in neurotrauma care. Dr Hawryluk is leading a world-wide effort – along with Dr Randall Chesnut from the University of Washington – to develop a modern treatment algorithm for the management of severe traumatic brain injury. Dr Hawryluk is AOSpine and Global Neuro Faculty and he sits on the curriculum committee of the later organization. He serves as the Neurotrauma Section Editor for Operative Neurosurgery and he also sits on the Steering Committee of the Paralyzed Veterans of America. He is the recipient of numerous prestigious awards for academic achievements such as the Murray Goldstein Award of the National Neurotrauma as well as humanitarian awards such as the University Health Network’s Sopman Humanitarian Award.

Dr Hawryluk has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.

ORCiD: 0000-0002-5604-7057


Dr Olabisi Sanusi

Dr Olabisi Sanusi is a Nigerian born board eligible neurosurgeon practicing in Lansing, MI. Dr Sanusi received her medical degree from Pennsylvania State College of Medicine and was inducted into the medical honor society Alpha Omega Alpha for high achievement and her exemplary nature. She went on to complete her residency at Northwestern Memorial Hospital in Chicago. After completing two chief years during residency, she went on to complete a skull base fellowship at the Oregon Health and Science University in Portland, Oregon. Dr Sanusi is married and has a son. In her spare time, Dr Sanusi enjoys listening to audiobooks.


Marie-Noëlle Hébert-Blouin, MD, MSc

Marie-Noëlle Hébert-Blouin, MD, MSc, is an assistant professor in the Division of Neurology and Neurosurgery at McGill University, in Montreal, Canada. She is an academic neurosurgeon in the Department of Neurology and Neurosurgery at the Montreal Neurological Hospital and Institute, part of the McGill University Health Center. She received her medical degree and master's degree in neurological sciences from McGill University, where she also completed a residency in neurosurgery. Dr Hébert-Blouin completed a 2-year post-residency fellowship in peripheral nerve surgery at the Mayo Clinic under the supervision of Dr Robert Spinner. Her practice focuses on the evaluation and treatment of peripheral nerve disorders, including traumatic, neoplastic, and entrapment pathologies.

Dr Hébert-Blouin has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.

ORCiD: 0000-0002-0581-1342


Brian Howard

Brian Howard, MD is an Assistant Professor of Neurosurgery and Radiology at Emory University School of Medicine in Atlanta, GA. Dr Howard’s practice is primarily in the comprehensive treatment of patients with neurovascular disease. In addition, his academic interest is in determining safety, outcomes and best practices for the neurosurgical and interventional treatment of neurovascular disease, including both retrospective datasets and involvement in prospective registries and randomized trials. He also has keen interest in surgical education.

Dr Howard completed neurosurgery residency at Emory University where he also did post-residency fellowship training in cerebrovascular and skull base surgery as well as interventional neuroradiology. Dr Howard is actively involved in organized neurosurgery in various roles in the Congress of Neurological Surgeons and the American Association of Neurological Surgeons.

Dr Howard has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.

ORCiD: 0000-0001-9134-0817


Benjamin Huang, MD, MPH

Benjamin Huang, MD, MPH, is a clinical associate professor of radiology and the director of the Neuroradiology Fellowship Program at the University of North Carolina in Chapel Hill, North Carolina. Dr Huang completed a diagnostic radiology residency and neuroradiology fellowship at the University of North Carolina. Following fellowship, Dr Huang joined the radiology faculty at the University of North Carolina in 2007. He is on the editorial board of the American Journal of Neuroradiology and serves on the scientific program committee of the Radiological Society of North America. His interests include imaging of the skull base and temporal bones.

Dr Huang has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.


Dr Christina Jackson

Dr Christina Jackson is a neurosurgery resident at the Johns Hopkins Hospital. She completed her undergraduate training at The University of Texas at Austin before completing her MD at Harvard Medical School. As Harvard Medical School, Dr Jackson completed a Harvard research fellowship where she worked on uncovering alterations to the immune phenotype of glioma patients and found the sequestration of lymphocytes in the bone marrow through the downregulation of T cell surface sphingosine 1-phosphate receptor 1 expression. She has a strong interest in benign, malignant, and skull base tumors. During residency, she completed an enfolded CAST-certified neurosurgical oncology fellowship and a NIH F32 post-doctoral fellowship furthering the understanding of and discovering strategies to overcome the immunosuppressive glioma tumor microenvironment with the goal of designing more tailored immune based therapies using single cell RNA sequencing. Dr Jackson will be pursuing a post-residency skull base fellowship at the University of Pittsburgh. Her long-term goal is to be a technically excellent skull base and brain tumor neurosurgeon and to continue to harness the immune system to develop novel therapies for central nervous system malignancies through scientific research and clinical trials.

ORCiD: 0000-0003-4210-7976


Jack I. Jallo, MD, PhD

Jack I. Jallo, MD, PhD is professor and vice chair for academic services for the department of neurosurgery at Thomas Jefferson University Hospital. He is also director of the Neurotrauma and Critical Care Program. He completed a neurotrauma fellowship at Temple University in Philadelphia, where he also completed his neurosurgical residency. He has edited a two-volume textbook on neurotrauma and critical care of brain and spinal injuries that has been translated into both Spanish and Chinese volumes.

Additionally, he has authored numerous chapters and peer-reviewed publications. He is an active member of several neurosurgical societies. His practice is university-based. He has an independent basic science laboratory whose focus is on traumatic brain injury as well as spinal cord injury. His clinical practice is mainly focused on disorders of the spine.

Dr Jallo has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.


Dr Andrew Jea

Dr Andrew Jea attended the University of Florida in Gainesville, Florida, where he obtained a bachelor of science in electrical engineering. He then entered medical school at the University of Miami School of Medicine in Miami, Florida, and graduated with Alpha Omega Alpha honors. Dr Jea completed his residency at the University of Miami/Jackson Memorial Hospital in Miami under the mentorship of Drs Barth Green and Roberto Heros, his pediatric neurosurgery fellowship at the Hospital for Sick Children in Toronto, Ontario, Canada under the tutelage of Drs James Drake and James Rutka, and his spine fellowship at the University of Miami with Dr Allan Levi.

Dr Jea's clinical practice is unique in that it includes the breadth of pediatric spinal disorders including deformity. He is also academically productive, with over 215 peer-reviewed articles and over 40 book chapters, mainly on the topic of pediatric spine. With collaborators from Rice University, Dr Jea was able to run a small, externally funded laboratory effort exploring the use of nanomaterials as scaffolds in neuroregeneration.

In 2020, Dr Jea joined Dr Ian Dunn and the Department of Neurosurgery at The University of Oklahoma College of Medicine, where he is Professor, Vice-Chairman, and Chief of Pediatric Neurosurgery at Oklahoma Children’s Hospital. Dr Jea will complete a master degree of business administration at Indiana University Kelley School of Business Physician MBA program in May 2021.

Dr Jea remains active on the national level as a member of the executive committees of the Section of Neurological Surgery of the American Academy of Pediatrics and AANS/CNS Joint Section on Pediatric Neurological Surgery. Dr Jea is an active fellow of the Scoliosis Research Society. Dr Jea has served as an editorial board member for AANS Neurosurgeon and has been selected to serve on the editorial boards of Pediatrics and Journal of Neurosurgery: Pediatrics.
Away from work, Dr Jea enjoys spending time with his true loves—his wife, Lourdes, and 3 boys, Matthew, Michael, and Ryder.

Dr Jea has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.


Maribeth Johnson

Maribeth Johnson retired from the Medical College of Georgia at Augusta University in June 2014 as an Assistant Professor in the Department of Biostatistics and Epidemiology where she remains an Adjunct Assistant Professor. Maribeth has been a consulting research statistician for over 25 years, collaborating in the design and analysis of medical research, the interpretation of results, and the publication of over 120 manuscripts in refereed journals. She also has experience teaching biostatistics at the graduate level. Maribeth has MS degrees in Animal Breeding and Genetics from Virginia Tech (1980) and in Statistics from the University of Georgia (1992).

Dr Johnson has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.

ORCiD: 0000-0001-5468-4522


Dr Han Jo Kim

Dr Han Jo Kim received his MD from Columbia University College of Physicians and Surgeons in New York and a completed a residency in Orthopaedic Surgery at the Hospital for Special Surgery. He then completed a Spine Fellowship at Washington University in St. Louis followed by an additional fellowship in Cervical Spine Surgery.

Currently, he serves as the Spine Fellowship Director and Fellowship Committee Chair for the Hospital for Special Surgery. He also serves as a member of the Resident Leadership Group, Graduate Medical Education, Global Education Council Committees for the hospital.

His practice focuses on Adult and Pediatric Spinal Deformity and Cervical Spine Surgery and he performs over 350 operations a year. He is an active member of the International Spine Study Group and has research interests in adult spinal deformity and the cervical spine. Dr Kim has a particular interest in adult spinal deformity surgery outcomes and improving the value proposition for complex spine surgery. He is also interested in cervical deformity classifications systems that can guide surgical management.

He has authored over 220 peer-reviewed publications and has been invited guest lecturer around the globe for many international and national societies in addition to being visiting professor at Brown University, New York University, Mt. Sinai Medical Center, Montefiore and the University of Miami Medical Center. He is also an active member of the SRS, CSRS, AAOS, AOA and NASS and serves on committees for each of them.

Dr Kim receives royalties from ZimmerBiomet and K2M-Stryker, research support from ISSGF and is an investor in Relatable and Spine Stud

ORCiD: 0000-0002-7482-6994


Lawrence Kleinberg

Lawrence Kleinberg MD Associate Professor, Co-Director Sterotactic Radiosurgery, Director of the Cyberknife Program.  Graduated from Yale Medical School 1989 and completed his Radiation Oncology training Sloan Kettering Cancer Cent 1993, He has practice Radiation Oncology at Johns Hopkins Hospital since then. His research interest are Radiosurgery for brain and spine tumors, improving outcome for glioblastoma and combining radiotherapy and immunotherapy.

Dr Kleinberg has performed consulting for Novocure, Accuray and is on the advisory board for Novocure.

ORCiD: 0000-0003-2473-2305


Dr Brian Kopell

Dr Brian Kopell is a Professor of Neurosurgery, Neurology, Psychiatry, and Neuroscience as well as Director of the Center for Neuromodulation at the Mount Sinai Health System. Dr Kopell has pioneered the use of intraoperative imaging during Deep Brain Stimulation (DBS) cases to supplement the microelectrode recording typically done to make a procedure that is safer and quicker for patients. He has performed over 1,000 DBS procedures.

A graduate of the NYU School of Medicine, Dr Kopell completed his residency at NYU Medical Center. He has undergone fellowship training in Functional and Restorative Neurosurgery at the Cleveland Clinic Foundation and the University of Zurich. He founded and has led the Restorative Neuroscience Program at the Medical College of Wisconsin (Milwaukee, WI) where his team performed over 400 DBS cases for movement disorders. Furthermore, Dr Kopell has participated and has been principal investigator in several clinical trials of emerging neuromodulation technologies targeting disorders such as Parkinson's disease, tremor, tinnitus, Tourette's syndrome and major depression.

Dr Kopell is a consultant for Abbott Neuromodulation, Medtronic and Elekta.

ORCiD: 0000-0002-6955-4787


Dr Ricardo Komotar

Dr Ricardo Komotar is associate professor of neurological surgery at the University of Miami School of Medicine. He graduated summa cum laude with a bachelor of science in neuroscience from Duke University, spending a year at Oxford University in England to focus on neuropharmacology. He received his medical degree from the Johns Hopkins University School of Medicine with highest honors and completed his internship and neurosurgical residency at Columbia University Medical Center/The Neurological Institute of New York, followed by a surgical neurooncology fellowship at Memorial Sloan-Kettering Cancer Center to specialize in brain tumors.

As director of the University of Miami Brain Tumor Initiative, Director of Surgical Neurooncology at the University of Miami, and Director of the UM Surgical Neurooncology Fellowship Program, Dr Komotar's main clinical interests are surgical and radiosurgical treatment of primary and metastatic brain tumors as well as meningiomas and pituitary lesions. Dr Komotar is a nationally recognized expert and leader in the field of brain tumors, performing nearly 500 procedures for these conditions each year using advanced, cutting-edge surgical/radiosurgical techniques.

His research interests include clinical trial development and translational neurooncologic investigations designed to pioneer new therapies for brain tumors. Author of over 450 peer-reviewed scientific articles, book chapters, and invited editorials, Dr Komotar has received research funding from the National Institutes of Health as well as other national and regional grants. He has served on the Executive Committee for the Congress of Neurological Surgeons and the Executive Board for the AANS/CNS Joint Section on Tumors. He is founder and director of the Annual Neurosurgery Charity Softball Tournament to benefit brain tumor research. He is a member of the Society of Neurooncology and reviewer for bothNeurosurgery and the Journal of Neurosurgery. Dr Komotar is also an Emmy®-nominated physician for his work on the series "Breakthrough Medicine."

Dr Komotar has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.


John S. Kuo, MD, PhD, FAANS, FACS

John S. Kuo, MD, PhD, FAANS, FACS, is the inaugural Chair of Dell Medical School’s Dept. of Neurosurgery at the University of Texas at Austin, Surgical Director of the Mulva Clinic for the Neurosciences, and tenure Professor of Neurosurgery and Oncology.

He was previously tenured Professor of Neurosurgery and Human Oncology, Director of the Comprehensive Brain Tumor Program, and Chair of the Carbone Cancer Center CNS Tumors Group at the University of Wisconsin-Madison. Dr Kuo graduated from Harvard with summa cum laude and Phi Beta Kappa honors, then simultaneously earn MD and PhD degrees from Harvard Medical School (Harvard-MIT Division of Health Sciences and Technology) and MIT’s Whitehead Institute for Biomedical Research with an NIH-funded MSTP fellowship. Dr Kuo trained in clinical neurosurgery with Drs. Weiss, Apuzzo, Giannotta and McComb at the University of Southern California, and completed an American Brain Tumor Association postdoctoral fellowship with Dr Rutka at University of Toronto’s Labatt Brain Tumour Research Centre. He is a board-certified neurosurgeon specializing in surgery for benign and malignant brain tumors, and directs an NIH-funded translational research lab studying cancer stem cell biology to develop novel therapies and improve patient outcomes. In addition, he leads and collaborates on many national and cooperative group clinical trials of new brain tumor therapies. Dr Kuo’s research on novel cancer-targeting agents with diagnostic, fluorescent and therapeutic applications was featured on the covers of Science Translational Medicine and Neurosurgery. His many honors and awards include the Preuss award, Headrush Brain Tumor Research Professorship, the National University of Singapore Yeoh Ghim Seng Visiting Professorship in Surgery, Loff Memorial Fund for GBM research, election to the American Academy of Neurological Surgeons, Society of University Surgeons and American College of Surgeons, NREF Young Clinician Investigator, Sigma Xi and multiple teaching awards. Dr Kuo serves as Tumor Section Editor of Operative Neurosurgery and World Neurosurgery, Co-Editor of Neurosurgery Watch, and as an Associate Editor for Neuro-Molecular Medicine, Scientific Reports, and Frontiers in Oncology. He is past Chair of the American Association of Neurological Surgeons Membership committee, and serves on the Congress of Neurological Surgeons Education Division and AANS/CNS Joint Tumor Section Executive Committee.

Dr Kuo has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.

ORCiD: 0000-0001-6809-4806


Dr James Lah, MD, PhD

Dr James Lah, MD, PhD is Associate Professor and Vice Chair of the department of Neurology at Emory University. He directs the Cognitive Neurology Program, serves as Associate Director and Clinical Core Leader of the NIA-funded Emory Alzheimer’s Disease Research Center, and holds the Alice and Roy Richards Chair for Alzheimer’s Research. Dr Lah completed his dissertation project studying basic mechanisms of membrane traffic in the Department of Neurobiology and Cell Biology and earned his MD-PhD through the Medical Scientist Training Program at the Ohio State University College of Medicine. Following Residency training in Neurology, he remained on the faculty at Emory University where he has continued to pursue research in the field of Alzheimer’s and other neurodegenerative disorders, and has built a multidisciplinary team to care for individuals living with these disorders. Dr Lah has published over 100 articles in peer-reviewed journals and has conducted basic and clinical research funded through the NIH, Alzheimer’s Association, Hartford Foundation, Rotary CART Fund, American Federation for Aging Research, AHAF/Bright Focus Foundation, Goizueta Foundation, and numerous industry-sponsored clinical trials. His current research is focused on the development of improved biomarkers and identification of new therapeutic targets in Alzheimer’s and related disorders.

Dr Lah serves as site-PI or site-Investigator for clinical trials sponsored by the following companies: Biogen; Eisai; Eli Lilly; Merck; Hoffmann-La Roche; Avanir; Abbvie; Novartis; Genentech

ORCiD: 0000-0002-8810-620X


Dr David Langer

Dr David Langer is chairman of the Department of Neurosurgery at Lenox Hill Hospital. In 2013, Dr Langer was recruited to Lenox Hill Hospital as Director of Neurosurgery to begin to build on a vision of not only an outstanding clinical entity in the neurosciences but to create an entirely new environment for patients and their families. Dr Langer is a third-generation medical doctor and attended the University of Pennsylvania and its medical school. He completed his neurosurgical residency there and joined his chairman, Eugene S. Flamm, MD, when he left Penn to embark on the establishment of a new neurosurgical institute in New York City in 1998. He remained in New York City until 2010, when he joined North Shore-LIJ and Dr Raj Narayan's new academic neurosurgery department in 2010 after completing a neuroendovascular fellowship at SUNY/Buffalo.

Dr Langer has focused the majority of his clinical and academic attention to diseases of the brain vessels and is an internationally recognized expert in cerebral revascularization and cerebral aneurysms. He additionally is recognized as a thought leader and expert in the uses of consumer information technology in the medical space and has lectured on the design and implementation of these technologies.

Dr Langer has published on and spoken both nationally and internationally on vascular disorders such as aneurysms and arteriovenous malformations (AVM) of the brain and is one of the few remaining expert cerebral bypass surgeons in the country. In 2011, Dr Langer established the Moyamoya Center of New York and embarked on the development of a project focused on the use of social networking technology and video to enhance the patient experience and improve the medical record. This project has grown into Cirrus Health, which continues to disrupt the status quo in patient communication and the current electronic medical record.

Dr Langer serves as a paid consultant for Olympus Inc.

ORCiD: 0000-0001-6028-2765


Michael Lawton, MD

Michael Lawton, MD is the Tong-Po Kan Endowed Chair, professor of neurological surgery, and vice-chairman of the department of neurological surgery at the University of California, San Francisco. He is chief of vascular neurosurgery, specializing in the surgical treatment of aneurysms, arteriovenous malformations, arteriovenous fistulas, cavernous malformations, and cerebral revascularization, including carotid endarterectomy. As chief of one of the busiest cerebrovascular service in the west coast for over 17 years, he has experience in surgically treating over 3500 brain aneurysms and over 650 AVMs. He is also trained in the endovascular treatment of aneurysms.

Dr Lawton directs and conducts his research at and the UCSF Center for Cerebrovascular Research (CCR), a collaborative research group funded by grants from the National Institutes of Health that investigates the physiology of cerebral circulation and the pathophysiology of vascular malformations. His basic science investigations study the formation, underlying genetics, and rupture of brain AVMs, as well as the hemodynamics, rupture, and computational modeling of brain aneurysms. His clinical investigations study the anatomy of microsurgical approaches to vascular lesions and efficacy of aneurysm, AVM, and bypass surgery. He is the principle investigator of a U54 grant and program director of the Brain Vascular Malformation Consortium (BVMC), a multicenter group studying malformations associated with hereditary hemorrhagic telangiectasia, cavernous malformations, and Sturge-Weber syndrome.

He has published over 300 peer-reviewed articles, over 50 book chapters, and 3 textbooks, includingSeven AVMs: Tenets and Techniques for Resectionand Seven Aneurysms: Tenets and Techniques for Clipping, which has won numerous awards and sold more copies than Yasargil's Microneurosurgery. His awards include the Young Neurosurgeon Award from the World Federation of Neurological Societies, the Harold Rosegay Teaching Award, and the Diane Ralston Clinical and Basic Science Teaching Award. He has given over 500 invited lectures nationally and internationally, including visiting professorships at over 40 neurosurgical institutions. He has been active in resident teaching courses, directing the CNS Anatomy Course for Senior Residents, developing and co-directing the AANS Vascular Skills Course, and directing industry-sponsored anatomy courses and teaching programs for residents nationally and internationally to observe vascular neurosurgery. He co-founded Mission:BRAIN, a teaching mission to raise the level of neurosurgical technique practiced in developing countries, and has conducted missions in Mexico and the Philippines.

Dr Lawton is a consultant for Zeiss, Medtronic, Stryker Mizuho, and receives royalties from Thieme Medical Publisher.


Dr. Ann Liu

Dr Liu is a neurosurgery resident at the Johns Hopkins Hospital in Baltimore, Maryland. She graduated from medical school at the Wake Forest School of Medicine in Winston-Salem, North Carolina. She completed her undergraduate degree at the University of North Carolina-Chapel Hill, where she founded and published Carolina Scientific, a semesterly journal highlighting undergraduate research.


James K. Liu, MD, FACS, FAANS

James K. Liu, MD, FACS, FAANS is the Director of the Center for Skull Base and Pituitary Surgery at the Rutgers Neurological Institute of New Jersey, and Associate Professor of Neurological Surgery and Otolaryngology-Head and Neck Surgery at Rutgers New Jersey Medical School. He is also Director of the Brain Tumor Center and Cerebrovascular Bypass Program, and board certified by the American Board of Neurological Surgeons.

Dr Liu was born in Taiwan and raised in Cupertino, California. He graduated summa cum laude from UCLA with Phi Beta Kappa honors, and obtained his MD from New York Medical College with AOA honors. After completing a neurosurgery residency at the University of Utah in Salt Lake City, he was awarded the Dandy Clinical Fellowship by the Congress of Neurological Surgeons, and obtained fellowship training in Skull Base, Cerebrovascular Surgery & Neurooncology at Oregon Health & Science University in Portland.

Dr Liu is renowned for his comprehensive treatment of complex brain tumors and skull base lesions, including pituitary tumors, acoustic neuromas, meningiomas, craniopharyngiomas, chordomas, and jugular foramen tumors. His robust clinical practice encompasses both traditional open and minimally invasive endoscopic endonasal skull base approaches. He also specializes in cerebrovascular bypass procedures for carotid occlusion, complex aneurysms and skull base tumors, as well as microvascular decompression for trigeminal neuralgia and hemifacial spasm.

As one of the most active researchers in his field, Dr Liu has published extensively with over 200 peer-reviewed publications and 25 textbook chapters. He has taught many hands-on courses in skull base surgery and has lectured extensively nationally and internationally throughout North America, Europe, and Asia. Dr Liu's research is focused on the development of innovative and novel skull base and endoscopic techniques, quantitative surgical neuroanatomy, microsurgical and microvascular anastomosis skills training, and pituitary tumor biology.

Dr Liu is an active member of the American Association of Neurological Surgeons, Congress of Neurological Surgeons, North American Skull Base Society, Pituitary Network Association, The Facial Pain (Trigeminal Neuralgia) Association, AANS/CNS Cerebrovascular Section, Tumor Section. He serves on the medical advisory board of the Acoustic Neuroma Association of New Jersey.

Dr Liu has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.


Dr Simon Lo

Dr Simon Lo is an internationally renowned radiation oncology expert in brain and spine tumors, stereotactic radiosurgery and stereotactic body radiotherapy. Dr Lo earned his medical degree from the Faculty of Medicine, The Chinese University of Hong Kong. He completed a residency in Clinical Oncology under the Fellowship of Royal College of Radiologists, UK curriculum at Queen Elizabeth Hospital, Hong Kong before performing a second residency in Radiation Oncology at University of Minnesota. He is currently Professor of Radiation Oncology and Vice Chair for Strategic Planning of Radiation Oncology as well as Professor of Neurological Surgery at University of Washington School of Medicine. He was previously the Director of Neurologic Radiation Oncology and Radiosurgery Services at University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center as well as Professor of Radiation Oncology at Case Western Reserve University in Cleveland, OH. He has been inducted as a Fellow of American College of Radiology (FACR) and is currently the President-elect for the Council of Affiliated Regional Radiation Oncology Societies, the radiation oncology chapter of the American College of Radiology (ACR). He is also a Fellow of American Society for Radiation Oncology (FASTRO). He has participated in or led international/ national practice guidelines in brain, bone and spinal metastases. He has been invited as a panel member to serve on the American Academy of Neurological Surgeons (AANS)/ Congress of Neurological Surgeons (CNS) Taskforce in Brain Metastases to help develop evidence cased practice guidelines for brain metastases. Dr Lo is the lead editor for 3 textbooks with one dedicated to stereotactic body radiotherapy for spinal metastasis and a co-editor of a 4th textbook dedicated to brain and spine radiosurgery. He has published over 180 peer reviewed papers and has given numerous lectures or training courses in prestigious meetings/ conferences in the US, Canada, Europe and Asia and numerous prestigious universities in the US, Canada, Germany and Asia.


Dr Darlene A. Lobel

Dr Darlene A. Lobel is a board certified neurosurgeon who is internationally known as an expert in the treatment of essential tremor and other movement disorders. She earned a Bachelor of Science degree from Duke University and her Medical Doctorate from Medical College of Georgia. She completed clinical fellowships in Stereotactic and Functional Neurosurgery and Epilepsy at UCLA and Emory, finishing training in 2007. She also completed two research fellowships, first in Grenoble, France, where she worked for two years with Professor Alim-Louis Benabid at Clinatec on the clinical protocol and implementation of a brain computer interface system, designed to aid quadriplegic patients. She then completed a fellowship in the Neural Engineering Laboratory at Mayo Clinic in Rochester, Minnesota, where she worked on the design and preclinical assessment of an intraspinal microstimulation system to restore neurologic function after spinal cord injury. Dr Mayo worked for two years as a Neurosurgeon and Assistant Professor at University of Florida-Jacksonville and for nearly five years as a Neurosurgeon and Associate Professor of Neurosurgery and Biomedical Engineering at the Cleveland Clinic, where she had a busy practice treating patients with essential tremor and Parkinson’s disease. She also co-led an essential tremor support group for two years in the Cleveland area.

Dr Mayo is a renowned author with over 25 publications, including peer-reviewed manuscripts, books, and book chapters, and is an internationally acclaimed speaker. She has spent years researching ways to improve tremors, having served as a consultant and lead investigator on clinical trials in the U.S. and abroad. She also serves as an ad-hoc reviewer for neurosurgical and biomedical engineering journals, and serves on grant review panels, as reviewer and as chair. Her expertise is widely sought after as a reviewer, invited speaker, and as an expert in deep brain stimulation by other scientists and researchers.

She has a passion for teaching, which extends not only to medical students and residents in training, but to her patients and to anyone who is looking to learn more about medical conditions. Dr Mayo is an internationally acclaimed speaker and holds leadership positions in the Council of State Neurosurgical Societies. She has served as Co-Investigator and Consultant in clinical trials in the US and in France, has authored numerous publications, including peer-reviewed manuscripts and book chapters, serves as an ad-hoc reviewer for neurosurgical and biomedical engineering journals, and serves on grant review panels, as reviewer and as chair. Her expertise is widely sought after as a reviewer, invited speaker, and as an expert in deep brain stimulation by other scientists and researchers.

Dr Lobel has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.


M. Beatriz S. Lopes

M. Beatriz S. Lopes received her MD and PhD degrees at the University of São Paulo in São Paulo, Brazil. She completed her Anatomic Pathology and Neuropathology training at the University of São Paulo followed by a Clinical and Research Neuropathology Fellowship at the University of Virginia in Charlottesville, Virginia, USA.

She joined the faculty of the Department of Pathology at the University of Virginia in 1993 where she is now the Harrison Distinguished Teaching Professor of Pathology and Neurological Surgery and the Chief of the Neuropathology and Autopsy Services. Dr Lopes has been the Director of the ACGME-accredited Neuropathology Fellowship Program at that Institution since 2003.

Her clinical and research expertise is in brain tumors and pituitary pathology with over 160 peer-reviewed manuscripts, 40 textbook chapters, and one book in these areas. She has co-authored several chapters in both the WHO Classification of Brain and Pituitary Gland Tumors since 2000 and 2004, respectively, and was a member of the WHO Consensus and Editorial Meeting of the upcoming 4th Edition of the WHO Classification of Tumors of the Pituitary Gland.

Dr Lopes has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.


Christopher J. Madden, MD

Christopher J. Madden, MD, is a Professor in the Department of Neurological Surgery at UT Southwestern Medical Center and the Clinical Executive Director of the Peter O'Donnell Jr. Brain Institute.

Dr Madden earned his medical degree at University of Texas Health Science Center at San Antonio. He performed his neurological surgery residency at The Ohio State University and completed a fellowship in skull base surgery at Addenbrooke’s Hospital in Cambridge, England.

Dr Madden was Chief of Neurosurgery at Parkland Hospital, a level I trauma center, from 2003 to 2012. He has also served in a variety of administrative roles, including as Chief Medical Officer of Parkland Hospital and Associate Vice President for Parkland Health & Hospital System Affairs.

Dr Madden is a member of multiple professional organizations, including the American Association of Neurological Surgeons, the Congress of Neurological Surgeons, and the American College of Surgeons.

He has been honored by Best Doctors Inc. and D Magazine as one of the best neurosurgeons in the nation and city, respectively. He is a former president of the Texas Association of Neurological Surgeons.

Dr Madden has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.


Dr Mark Mahan

Dr Mark Mahan is a neurosurgeon who specializes in complex peripheral nerve surgery, spine surgery, and neurologic reconstruction for diseases such as spasticity, spinal cord injury, nerve injury, and stroke. He completed his residency at the internationally recognized Barrow Neurologic Institute and did fellowship training at the Mayo Clinic and University of California in San Diego. He is an active researcher in spinal and nerve disorders, publishing scholarly articles routinely and pursuing laboratory research to improve patient outcomes.

He is the only neurosurgeon in the Rocky Mountains who performs complex nerve surgery. Dr Mahan treats nerve tumors, whether malignant, benign, or related to genetic syndromes such as neurofibromatosis; nerve entrapments, such as carpal tunnel syndrome, cubital tunnel syndrome, thoracic outlet syndrome, or patients with prior surgery needing revision; nerve injuries, such as brachial plexus injuries, nerve lacerations or trauma, or iatrogenic (related to other surgery) nerve injuries; nerve pain, such as meralgica paresthetica, occipital neuralgia, or other conditions requiring nerve stimulation; functional nerve reconstruction, including for post-stroke spasticity or palsy and dystonia; as well as many other conditions.

Dr Mahan also performs the complete range of spinal surgery, including oncologic, deformity, minimally invasive, and spinal trauma.

Outside of work, Dr Mahan relaxes by getting out into the wilderness with his family. He can often be found running early in the morning.

Dr Mahan is a consultant for AxoGen, joimax, and Gecko Biomedical.

ORCiD: 0000-0002-9777-4701


Dr Mascitelli

Dr Mascitelli received his undergraduate degree at the University of Pennsylvania and medical education at Weill Cornell Medical College. He trained in Neurological Surgery at Mount Sinai Hospital and received fellowship training in Endovascular Neurosurgery at Mount Sinai Hospital and Cerebrovascular Surgery at the Barrow Neurological Institute. He currently is an Assistant Professor of Neurosurgery at UT Health San Antonio and the Medical Stroke Director at St. Luke’s Baptist Hospital in San Antonio. He has authored numerous peer reviewed publications and book chapters on cerebrovascular neurosurgery. He is the principle investigator of a prospective, multi-center aneurysm registry and is actively participating in other research endeavors studying both aneurysms and stroke.

Dr Mascitelli has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.

ORCiD: 0000-0001-9409-5810


Dr Courtney McCracken

Dr Courtney McCracken currently serves as the Director of the Pediatric Biostatistics Core in the Department of Pediatrics at Emory University. Dr McCracken graduated from the University of Georgia with a B.S in Mathematics in 2006, and in 2009, she completed her Masters in Biostatistics from Augusta University (formerly Medical College of Georgia). In 2013, Dr McCracken completed her PhD in biostatistics from Augusta University under the direction of Dr Stephen W. Looney. Since 2011, Dr McCracken has been consulting with pediatric researchers in the Department of Pediatrics at Emory University. She has over 150 peer-reviewed publications spanning a wide-range of pediatric diseases and conditions. Her research interests include survival analysis, regression modeling strategies, and meta-analysis. She currently resides in Atlanta Georgia with her husband, a Neurosurgical Oncologist, and their two children.

Dr McCracken has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.

ORCiD: 0000-0001-7941-1256


Matthew J. McPheeters, MD, MBA

Matthew J. McPheeters, MD, MBA is a neurosurgery resident at the University at Buffalo. Dr McPheeters grew up in Minneapolis, MN, and completed his undergraduate education at Baylor University in Waco, Texas, where he graduated magna cum laude. He received his Medical Doctorate and Master of Business Administration at the University of Minnesota, where he served as the president of the medical student council and worked as a health and medicine content creator at Khan Academy. Dr McPheeters also serves as an officer in the US Army Reserves.

Dr McPheeters clinical and research interests include open and endovascular neurosurgery as well as neurotrauma and neurocritical care medicine. In addition to his clinical interests, Dr McPheeters focuses on improving medical education through digital media and promoting quality scholarly publication.

Financial disclosures: none

ORCiD: 0000-0002-7289-3093


Eric A. Mellon, MD, PhD

Eric A. Mellon, MD, PhD is an Assistant Professor in the Departments of Radiation Oncology and Bioengineering at the University of Miami, Sylvester Comprehensive Cancer Center, Miller School of Medicine. He is a graduate of the Physician Scientist Training Program of the University of Pennsylvania where he earned his PhD in MRI Physics. He is a board-certified radiation oncologist after completion of residency training at the H. Lee Moffitt Cancer Center in Tampa, FL. Dr Mellon has published over fifty peer-reviewed articles on emerging MRI techniques for cancer and clinical radiation oncology--mostly in brain, spine, and pancreatic cancers. Clinically, he specializes in radiotherapy for tumors of the central nervous system and serves as co-leader of the neurologic clinical research group at the Sylvester Cancer Center. He is principal investigator and co-investigator on two NIH-funded trials for magnetic resonance spectroscopy guided radiotherapy of glioblastoma and assessment of response to therapy for brain metastases. His current basic research interests utilize MRI to probe the tumor microenvironment during therapy, giving information beyond just tumor size to evaluate early treatment response.

Disclosures: Dr Mellon is a former full-time employee of Elekta (manufacturer of the Gamma Knife system). He received travel funding from Viewray for presentation of data on the Viewray MRI-guided radiotherapy system in 2018. He is on the speaker's bureau for the Varian Hyperarc radiosurgery system.

ORCiD: N/A


Dr Alon Mogilner

Dr Alon Mogilner is associate professor of neurosurgery and anesthesiology at New York University School of Medicine and the director of the Center for Neuromodulation at NYU Langone Medical Center. He received his bachelor's and master's degrees from Columbia University in computer science. He received his MD as well as a PhD in physiology and neuroscience at NYU School of Medicine, where his research focused on functional imaging of the brain and neuronal plasticity. He then completed residency training in neurosurgery, as well as a fellowship in functional and stereotactic neurosurgery, with Dr Ali Rezai at NYU Medical Center.

His clinical interests include the use of neuromodulation as well as lesioning techniques to treat a variety of neurological disorders including movement disorders, chronic pain/headache, and psychiatric disorders. His research interests focus on the use of functional neuroimaging (fMRI, MEG) to elicit the mechanisms of action of neuromodulation.

Dr Mogilner is a past president of the American Association of Neurological Surgeons/Congress of Neurological Surgeons Joint Section on Pain, as well as a board member of the American Society for Stereotactic and Functional Neurosurgery (ASSFN). He is a former board member of the North American Neuromodulation Society (NANS), as well as the founding webmaster of the World Federation of Neurosurgical Societies (WFNS) website.

ORCiD: 0000-0003-1493-0463


Fadi Nahab, MD

Fadi Nahab, MD, recently completed his tenure as the Medical Director of the Emory University Hospital Comprehensive Stroke Center (2008-2018) and the Emory University Hospital Midtown Primary Stroke Center (2013-2018). He is currently assisting the Emory Johns Creek Stroke Primary Stroke Center as their new Stroke Director.

Dr Nahab was born in Baghdad, Iraq and immigrated with his family to the US during his childhood. He graduated from La Sierra University in California with a BS in Biology and obtained his MD at Loma Linda University. He completed his internship at UCLA before coming to Georgia for neurology residency and vascular neurology fellowship at Emory University.

In combination with an outstanding stroke team, he led Emory University Hospital to becoming the 1st certified Comprehensive Stroke Center in Metro Atlanta and the 1st to successfully recertify in Georgia. His clinical practice is focused on the treatment of cerebrovascular disease and his research interests include biomarkers to guide the treatment of cryptogenic stroke patients, acute stroke treatment, dietary behaviors in stroke prevention and the treatment of intracranial atherosclerosis with more than 60 publications.

He is a previous chief resident in Neurology, Neurology Teacher of the Year at Emory University and enjoys traveling with his family and golfing.

Dr Nahab has a patent pending on markers of coagulation and hemostatic activation to guide antithrombotic therapy in patients with cardiovascular and cerebrovascular disease.


Dr Aditya S. Pandey

Dr Aditya S. Pandey is the surgical director of the Comprehensive Stroke Center at the University of Michigan and the associate director of the Neurosurgery Residency Program. He gained his bachelor of science degree in biological and engineering sciences from Washington University in St. Louis. He achieved his medical degree in 2001 from Case Western Reserve University. He attended Thomas Jefferson University Hospital for neurosurgical residency training, followed by fellowship training in cerebrovascular and endovascular neurosurgery.

Dr Pandey's clinical interests are in the treatment of cerebrovascular diseases such as carotid stenosis, ischemic and hemorrhagic stroke, subarachnoid hemorrhage, arteriovenous malformations, and spinal vascular pathology. He has participated in numerous clinical trials, including the MISTIE III, HEAT, FEAT, and PAC studies. Currently, he is the principal investigator for the SPAR (seizure prophylaxis in aneurysm repair) trial, which will assess the need for seizure prophylaxis in patients undergoing microsurgery for elective aneurysm treatment.

Dr Pandey's research interests include: clinical outcome evaluations, analyses of population-based datasets, utilization of histotripsy for treating brain tumors as well as ICH, and the evaluation of early brain injury in a rat SAH model. He has been involved in numerous multidisciplinary research endeavors leading to R21, R03, and AHA grants. Dr Pandey's research efforts have culminated in the publication of more than 100 peer-reviewed manuscripts. He has presented at national and international conferences.

Dr Pandey is funded by Medtronic for a research grant (an application based research grant) and has invested in FlexDex and Nextgen Biologics.

ORCiD: 0000-0003-0789-4273


Paul Park

Paul Park was born in Los Angeles, CA, and attended the University of California, Los Angeles for college, where he earned bachelor's and master's degrees in biology. Dr Park subsequently obtained a medical degree from the University of Michigan and completed a neurosurgical residency at the University of Michigan.

Given his interest in the spine, Dr Park completed an enfolded fellowship at the Cleveland Clinic Spine Institute as well as a post-residency fellowship in minimally invasive spinal surgery at the Semmes-Murphey Clinic. He is now an associate professor of neurosurgery at the University of Michigan and director of minimally invasive spine surgery. Dr Park has a diverse clinical practice treating degenerative disease, deformity, tumor, infection, and trauma, as well as complex revision conditions. Dr Park also has varied research interests, including laboratory research on spinal oncology and degenerative disc disease as well as active involvement in many investigator-initiated and sponsored clinical trials involving spinal deformity, minimally invasive surgery, arthroplasty, spinal cord injury, spinal infection, and health services.


Suzanne Penna

Suzanne Penna is an Assistant Professor in the Department of Rehabilitation Medicine, Neuropsychology Division at Emory University School of Medicine. She completed her PhD in clinical and neuropsychology at Georgia State University, and completed her neuropsychology internship at Yale University School of Medicine, and Fellowship training at University of Alabama Birmingham. Dr Penna is Board Certified in neuropsychology by the American Board of Professional Psychology/American Board of Clinical Neuropsychology. She is the director of training for Emory’s neuropsychology program, from graduate to fellowship levels. Dr Penna serves as the Traumatic Brain Injury Clinical Director for Emory Veterans Program. Her research focus is on examining cognitive changes associated with chronic medical illness. She also has a strong interest in research on individuals with traumatic brain injury (TBI). This includes both outcome research in severe brain injury, and clinical profile of mild TBI. Specific populations include veterans with mTBI from blast injury and sports concussion.

Dr Penna has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.

ORCiD: 0000-0002-1460-5735


Dr Erika A. Petersen

Dr Erika A. Petersen directs the Section of Functional and Restorative Neurosurgery at UAMS Medical Center. She is an associate professor in the Department of Neurosurgery at UAMS. Dr Petersen is a board certified neurosurgeon whose clinical practice focuses on neuromodulation, treating movement disorders, spasticity, and chronic pain through surgical procedures and stereotactic radiosurgery. Dr Petersen's research interests focus on using high-resolution imaging to understand the functional interaction of centers within the brain and on developing new devices, indications and methods for treating chronic pain using neuromodulation. Her collaborations with colleagues in neuroradiology, neurology and psychiatry are aimed toward identifying new applications for the use of deep brain stimulation and neuromodulation for pain.

Dr Petersen completed her undergraduate education at Princeton University and received her medical degree from the University of North Carolina at Chapel Hill. She trained in neurosurgery at the University of Texas Southwestern with a fellowship in deep brain stimulation at the National Hospital for Neurology and Neurosurgery in London. Dr Petersen has served on the Joint Section on Pain of the American Association of Neurological Surgeons (AANS)/Congress of Neurological Surgeons (CNS) and the CNS Scientific Programming Committee and sits on the Executive Board of the American Society of Pain and Neuroscience. She serves as associate editor of stereotactic and functional neurosurgery for Operative Neurosurgery, and is on the editorial board of Neuromodulation. Dr Petersen lectures frequently at national and international meetings on deep brain stimulation, emerging applications of neuromodulation, and chronic pain management. She has authored several articles and book chapters in stereotactic and functional neurosurgery and neuroscience.


Dr Martin Piazza

Dr Martin Piazza is a neurosurgery resident at UNC Hospitals in Chapel Hill, North Carolina. He graduated from Princeton University with a degree in Chemistry and Materials Science. He then moved to North Carolina for medical school at Wake Forest School of Medicine, where he cultivated his interest in neurosurgery. During his medical school career, he spent a year in the Surgical Neurology Branch at the NIH in the Medical Research Scholars Program where he participated in and began to appreciate the importance of clinical, translational, and basic science research to the advancement of neurosurgery. As a resident, Dr Piazza has a wide array of interests, particularly early and accessible neurosurgical education, pediatric neurosurgical trauma, as well as adult and pediatric spinal deformity.


Julie G. Pilitsis, MD, PhD

Julie G. Pilitsis, MD, PhD is a professor of neurosurgery and of neuroscience at Albany Medical College and the chair of the Department of Neurosciences and Experimental Therapeutics. She completed her neurosurgery residency at Wayne State University in Detroit, MI. During that time, she also obtained a PhD in neurophysiology and became active in both basic science and translational research. She went on to complete a fellowship in functional neurosurgery at Rush University Medical Center in Chicago, IL, focusing in the neurosurgical treatment of movement disorders. She returned to her alma mater, Albany Medical College, in 2011, joining the division of neurosurgery as an associate professor of neurosurgery and in the Center for Neuropharmacology and Neurosurgery. She is well published and NIH-funded in the arena of functional neurosurgery. She is the current immediate past chair of the Joint Section on Pain of the American Association of Neurological Surgeons (AANS)/Congress of Neurological Surgeons (CNS) and an Executive Council Member of the American Society for Stereotactic and Functional Neurosurgery. She has served as an ex-officio member of the NANS Board of Directors, during which time she was the first chair of the Women in Neuromodulation Section. She is passionate about neuromodulation and sponsoring junior faculty in this arena.

Dr Pilitsis is a consultant for Boston Scientific, Nevro, Jazz Pharmaceuticals, and Abbott and receives grant support from Medtronic, Boston Scientific, Abbott, Nevro, Jazz Pharmaceuticals, GE Global Research, SBIR 1R43NS107076-01A1, and NIH 2R01CA166379-06. She is medical advisor for Aim Medical Robotics and Karuna and has stock equity.

ORCiD: 0000-0002-6488-9692


Matthew B. Potts

Matthew B. Potts is an Assistant Professor of Neurological Surgery and Radiology at the Northwestern University Feinberg School of Medicine in Chicago, Illinois. He was born in Fairfax, Virginia, attended the Thomas Jefferson High School for Science and Technology, and received an undergraduate degree in Biology from the Massachusetts Institute of Technology. He graduated from the University of California, San Francisco School of Medicine in 2007. After his third year, he was awarded a Howard Hughes Medical Institute Medical Student Research Fellowship to study neurogenesis in traumatic brain injury. He then completed a general surgery internship and trained in neurological surgery at the University of California, San Francisco under Dr Mitchel Berger. During his residency, he was awarded an NIH National Research Service Award to study transcriptional regulation in neurogenesis. After completing residency in 2013, he completed a fellowship in endovascular and cerebrovascular surgery at the New York University School of Medicine under Drs. Howard Riina and Peter K. Nelson. He was subsequently recruited to the Northwestern University Department of Neurological surgery to perform both open cerebrovascular and endovascular surgery.

Dr Potts specializes in the surgical and endovascular treatment of vascular pathologies of the brain and spinal cord. He has a particular interest in the treatment of aneurysms, arteriovenous malformations, cavernous malformations, arteriovenous fistulas, and stroke, as well as in medical student and resident education.

Dr Potts has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.

ORCiD: 0000-0002-0534-5097


Nader Pouratian, MD, PhD

Nader Pouratian, MD, PhD, is associate professor of neurosurgery, radiation oncology, and bioengineering at UCLA, where he is the director of neuromodulation, stereotactic radiosurgery, and peripheral nerve surgery programs. He specializes in surgeries to restore and preserve brain function, including deep brain stimulation for movement disorders (and other emerging indications) and surgeries that require brain mapping. In addition, he treats peripheral nerve and brachial plexus injuries and tumors. His research focuses on developing novel interventions and technologies for neurological restoration, with a specific interest in the physiology of Parkinson's disease and motor control. He serves as an active member of the Congress of Neurological Surgeons as well as the American Society of Stereotactic and Functional Neurosurgery (ASSFN).

Dr Pouratian does consulting and receives a medical grant from Medtronic, does consulting for Boston Scientific and Second Sight Medical Products, Inc, receives a research grant from BrainLab, and is a consultant and receives an educational grant for Abbott.

ORCiD: 0000-0002-0426-3241


Dr Ciarán J. Powers

Dr Ciarán J. Powers is an associate professor of neurological surgery, program director, and surgical director of the Comprehensive Stroke Center at The Ohio State Wexner Medical Center. Dr Powers was raised in Washington, DC, and obtained his undergraduate degree in history and science from Harvard College. At Harvard, he was a member of the Heavyweight Men's Crew and represented the United States on the Lightweight National Team at the World Rowing Championships in 2003. Dr Powers received his MD and PhD degrees from Georgetown University. He did his surgical internship and neurological surgery residency at Duke University. He also did a year-long neuroendovascular fellowship at Duke before going to the University of Wisconsin-Madison to complete this training. He is currently certified by the ABNS in neurological surgery and by the CAST in neuroendovascular surgery. Dr Powers specializes in open and endovascular treatment of structural cerebrovascular diseases, including brain aneurysms, brain AVM's, acute stroke, extracranial carotid stenosis, and moyamoya.

Dr Powers has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.

ORCiD: 0000-0001-7339-0001


Dr Gustavo Pradilla

Dr Gustavo Pradilla is an assistant professor in the Department of Neurosurgery at the Emory University School of Medicine. He serves as chief of the neurosurgery service at Grady Memorial Hospital and is the co-director of the Grady Skull Base Surgery Center. Dr Pradilla completed his training in neurosurgery at the Johns Hopkins Hospital and his fellowship training in cerebrovascular and skull base surgery at the University of Miami Miller School of Medicine in 2013. In addition, he received postdoctoral research training in cerebrovascular research and experimental neuro-oncology at the Johns Hopkins University School of Medicine prior to his residency training. Dr Pradilla is the director of the cerebrovascular research laboratory for the Department of Neurosurgery and a member of the Emory Brain Research Laboratory. He specializes in the surgical treatment of cerebrovascular disorders including aneurysms, arteriovenous malformations, and carotid artery stenosis, as well as in open and endoscopic surgery for brain and skull base tumors. His basic and clinical cerebrovascular research focuses on subarachnoid hemorrhage, intracerebral hemorrhage, and intracranial aneurysm formation, and his research in skull base surgery focuses on microsurgical anatomy and technique development in skull base surgery.

Dr Pradilla receives a Research Grant from NICO Corporation and Integra and is a consultant for Stryker.

ORCiD: 0000-0002-3661-3269


Daniel Prevedello, MD

Daniel Prevedello, MD, is an associate professor in the Department of Neurological Surgery and the director for the Minimally Invasive Cranial Surgery Program at the Ohio State University Wexner Medical Center.

Dr Prevedello's current research focus is on developing minimally invasive approaches to the brain and skull base that will result in the best surgical tumor resection possible with the least amount of disruption to normal tissue. Finding a patient treatment option that reduces the amount of long-term consequences for patients and their families is always his top priority.

Dr Prevedello's medical education began in Brazil, where he attended medical school and finished his residency in January 2005. He completed fellowships in neuroendocrine and pituitary surgery at the University of Virginia, and another in skull base and cerebrovascular surgery at the University of Pittsburgh. Dr Prevedello joined the Ohio State University in 2010 as an assistant professor of the Neurological Surgery Department. Two years later, he became associate professor of the same department, with an appointment at the Department of Otolaryngology as well.

Dr Prevedello Grants/Research Support from Storz; KLS-Martin; IntegraConsultant/Speaker Bureau from Medtronic; StrykerStockholder (Not as part of Mutual Fund) Elum; SolitonOther Financial Material Support including commercially supported faculty enrichment accts with KLS- Martin (Royalties); Mizuho (Royalties).

ORCiD: 0000-0003-0214-2339


Mark Proctor, MD

Mark Proctor, MD is the Neurosurgeon-in-Chief at Boston Children's Hospital as well as the Franc D. Ingraham Professor of Neurosurgery at Harvard Medical School. He currently serves as Chairman of the Board of the Physicians Organization and previously served as President of this organization.

Dr Proctor obtained his undergraduate degree at Dartmouth College and his medical degree at Columbia University College of Physicians and Surgeons. He went on to train in neurosurgical residency at Georgetown University followed by fellowship at Boston Children's Hospital. He has been on staff at Boston Children's Hospital since 1997.

Dr Proctor’s clinical interests include craniofacial disorders, complex pediatric spinal disorders, and neurotrauma. He is the director of the Brain Injury Center at Boston Children's Hospital, and nationally has been very involved in advocacy and injury prevention. He has been on the board of the Thinkfirst National Injury Prevention Foundation since 2002, serving as Chairman of the Board from 2009 - 2011. He is the immediate past Chairman of the Pediatric Section of the American Association of Neurological Surgeons and Congress of Neurological Surgeons, and is Past-President of the New England Neurosurgical Society.

Dr Proctor has a particular interest in the minimally invasive treatment of craniosynostosis. He is one of the world's leaders in performing this operation, and has studied the long-term effectiveness of this treatment option. He has an international referral base for the treatment of this condition. He, along with Dr Meara of plastic surgery, are also leaders in the treatment of complex craniofacial disorders and encephaloceles. They have many high profile cases coming from around the country and world for treatment of these conditions.

Dr Proctor has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.


Nabiha Quadri

Nabiha Quadri, MD is a PGY 3 neurosurgery resident at Saint Louis University. She is originally from Chicago, IL, and obtained her undergraduate degree in neuroscience from University of Illinois at Chicago. She completed her medical training at Saint Louis University School of Medicine. She has a wide range of clinical interests including pediatrics and functional neurosurgery. 

ORCiD: 0000-0001-9635-2032


Dr Carolyn Quinsey

Dr Carolyn Quinsey is a board eligible pediatric and adult neurosurgeon who specializes in minimally invasive surgery and endoscopy. Dr Quinsey is fellowship trained in pediatric neurosurgery and operates on children and adults using innovative techniques which include endoscopic, endonasal, eyebrow craniotomy, and microscopic approaches. She is one of a very few specialists using flexible neuroendoscopy, the newest technology and technique to effectively remove tumors and treat hydrocephalus without a shunt. Dr Quinsey is also a specialist in skull base and pituitary tumor surgery and performs endonasal tumor removal along with the ENT skull base team.

Dr Quinsey is also devoted to training the next generation of neurosurgeons both in the United States and abroad. She is currently the associate program director of the UNC Department of Neurosurgery where she directs the skull base lab for residents. Medical students and residents are mentored by Dr Quinsey in research and surgical training. She travels to Africa regularly and is currently developing a program to train neurosurgeons in Malawi. Dr Quinsey’s international public health initiative is to provide ongoing education in subspecialty areas, and to help doctors in Africa find the resources and support they need to provide self-sustaining neurosurgical care.

Dr Quinsey is a member of the Congress of Neurological Surgeons, the American Association of Neurological Surgeons, the Pediatric Section of the AANS/CNS, and the North American Skull Base Society. She has presented her research at several national and international meetings. She also completed a medical journalism rotation with ABC News and continues to be active in utilizing new ways to inform her patients about their health using media and online resources. Dr Quinsey has no conflicts of interest.


Dr P. B. Raksin

Dr P. B. Raksin, a graduate of Yale University and the University of Maryland School of Medicine, completed training in Neurological Surgery at Rush University Medical Center in 2002 and achieved ABNS certification in 2005. She is certified in Neurocritical Care through both the United Council for Neurologic Subspecialties (UCNS) and the Society of Neurological Surgeons (SNS) Committee on Advanced Subspecialty Training (CAST).

Dr Raksin currently holds the titles of Section Chief of Neurotrauma and Director of the Neurosurgery ICU at Cook County Hospital in Chicago, where she is also Vice-President of the Executive Medical Staff. She is a founding member of the Joint Guidelines Committee and chairs the Guidelines Subcommittee for the AANS/CNS Trauma Section Executive Committee. She is also a long-time faculty member for the Goodman Oral Boards review course.

Dr Raksin is co-Editor of the forthcoming Atlas of Emergency Neurosurgery (Thieme, anticipated publication Spring 2015). She is in her second term as the ranking officer for the Yale Class of 1992 and was recently named to the inaugural McDonogh School Board of Visitors. She is working toward a 12th marathon finish this Fall.

Dr Raksin has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.


Otto Rapalino, MD

Otto Rapalino, MD, is an assistant professor in the Department of Radiology at Harvard Medical School and staff neuroradiologist at the Massachusetts General Hospital. He is also the director of advanced MR neuroimaging and brain tumor imaging in the Department of Radiology at Massachusetts General Hospital. 

Dr Rapalino's clinical practice encompasses brain, spine, and head and neck imaging of adult and pediatric patients. His radiological expertise includes all aspects of Diagnostic Neuroradiology, with emphasis on stroke, brain tumors, neurodegenerative disorders, CSF disorders, CNS infections, and pediatric CNS disorders. 

His research focuses on the development of rapid MR neuroimaging techniques and advanced brain tumor imaging. 

Dr Rapalino has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.

ORCiD: 0000-0002-5038-4183


Jeffrey S. Raskin

Jeffrey S. Raskin is a board eligible pediatric neurosurgeon trained in general pediatric neurosurgery with special interest in functional and epilepsy surgery. He was recruited as tenure track Assistant Professor by Andrew Jea and Nicholas Barbaro to the section of pediatric neurosurgery at Riley Hospital for Children, Indiana University and Goodman Campbell Brain and Spine. As co-director of epilepsy surgery, Dr Raskin is expanding the comprehensive epilepsy center to include cutting-edge technology like responsive neurostimulation and robotic neurosurgery with laser interstitial thermal therapy for the treatment of neurooncology and epilepsy diagnoses. As director of movement disorders, Dr Raskin has developed clinical care pathways and multidisciplinary pathways for the treatment of dystonia and spasticity, including deep brain stimulation, intrathecal baclofen, and selective dorsal rhizotomy.

Dr Raskin is a member of the AANS and the CNS. He is an ad hoc reviewer for multiple neurosurgical journals and has published papers and book chapters with a subject predominance in quality and safety in neurosurgery as well as functional neurosurgery. Aside from ongoing clinical research, Dr Raskin has conducted bench research in learning and memory, brainstem control circuits in vasospasm, and functional partners of cone arrestin during phototransduction.

Jeffrey S. Raskin obtained a BA degree in neuroscience from Pomona College with completed time abroad at the University College of London in Developmental Neurobiology, received an MS in cell and neurobiology from the Keck School of Medicine at the University of Southern California, and an MD from the University of Nevada School of Medicine. He completed internship and residency in the department of neurological surgery at Oregon Health & Science University. He then pursued fellowship training in pediatric neurosurgery at Texas Children’s Hospital where he was clinical instructor of neurosurgery. After work Dr Raskin enjoys time with his family.

Dr Raskin has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.

ORCiD: 0000-0002-1865-9888


Wilson Z. Ray, MD

Wilson Z. Ray, MD is an associate professor in the Department of Neurological Surgery at Washington University, St. Louis. He received his medical degree from the University of Iowa and completed his neurosurgery training at Washington University. He completed a peripheral nerve fellowship at Washington University and complex spine fellowship at the University of Utah. He is the associate residency program director and co-director of the Center for Spinal Cord Injuries.

Dr Ray's clinical interests are spinal oncology, spinal cord injury, minimally invasive spine surgery, brachial plexus injuries, and nerve transfers.

Dr Ray's research interests are focused on axonal regeneration following both peripheral nerve and spinal cord injuries as well as the development of innovative technology targeting peripheral nerve/neuroprosthetic interfaces.

Dr Ray received grant support - NIH/NINDs, Department of Defense, has consulting agreements with Depuy/Synthes, Globus and Ownership stake with Acera surgical.

ORCiD: 0000-0002-3006-8562


Laura K. Reed, MD

Laura K. Reed, MD,is currently a neurosurgery resident physician at Baylor Scott & White in Temple, TX. She completed her undergraduate education at University of Maryland and her medical education at Virginia Commonwealth University. She was exposed to the field of neurosurgery at an early age and developed a strong passion for the specialty, especially cerebrovascular.

ORCiD: 0000-0002-7226-2179


Daniel K. Resnick, MD

Daniel K. Resnick, MD, is Professor, Vice Chairman, and Residency Program Director of Neurological Surgery at the University of Wisconsin School of Medicine and Public Health. He is a summa cum laude graduate of Princeton University, and an Alpha Omega Alpha graduate of the University of Pennsylvania School of Medicine. He performed his residency training in neurosurgery at the University of Pittsburgh and picked up a Master's degree in Neuroscience from Pittsburgh based on his spinal cord injury research. Dr Resnick did a rotation with Dr Benzel in New Mexico during his residency to further study spinal biomechanics.

Dr Resnick is an internationally known spinal surgeon and has particular expertise in minimally-incisional surgery, spinal tumors and degenerative disorders of the spine. His current research focuses on improving the quality of spinal surgery and he is particularly interested in tracking and improving meaningful patient outcomes.

Dr Resnick has served in multiple leadership roles in organized neurosurgery and spine surgery. He is Past President of the AANS/CNS Joint Spine Section, Past President of the Congress of Neurological Surgeons, and Past President of the North American Spine Society. He is currently a Director of the American Board of Neurological Surgeons.

He has over 200 peer-reviewed publications, another two hundred and fifty or so invited publications, and has presented over 600 scientific presentations. Among his presentations, he has been honored to serve as the Sonntag Lecturer for the American Association of Neurological Surgeons, The Fager Lecturer for the Lahey Clinic, The Jannetta Lecturer for the University of Pittsburgh, the Ved Sachdev Endowed Lecturer for Mount Sinai, the Whitcomb Lecturer for the New England Medical Society, and the Art Steffee Lecturer at the Cleveland Clinic.

Dr Resnick is on the advisory board of Nidus, a company founded by Zo Ghogawala which is developing methods to improve patient experience. There is no device and he is not paid, but does have potential stock options.


Dr Chenguan Wu

Dr Chenguan Wu is currently an Associate Professor of Neurosurgery and Radiology within the Division of Epilepsy and Neuromodulation Neurosurgery at the Vickie and Jack Farber Institute for Neuroscience at Thomas Jefferson Neurosurgery. He also serves as the Clinical Director of the Jefferson Integrated Magnetic Resonance Imaging Center (JIMRIC). He completed a combined degree program at Tufts University, where he earned his Bachelor of Science in Computer Engineering and Biomedical Engineering, his Master’s degree in Biomedical Engineering, and his Medical Degree. He went on to complete his residency in neurosurgery at Thomas Jefferson University before pursuing a fellowship in Stereotactic and Functional Neurosurgery. During his fellowship, he trained under Dr Ashwini Sharan at Thomas Jefferson University, Dr Kim Burchiel at Oregon Health and Science University, and Dr Marwan Hariz at the National Hospital for Neurology and Neurosurgery in London, UK. Dr Wu has a special interest in the use of surgical robotics, particularly in applications for stereotactic and functional neurosurgery. For more than five years now, he has routinely used surgical robots for applications in epilepsy surgery and in deep brain stimulation.

Dr Wu is a consultant for Abbott Corp, Boston Scientific, Medtronic, Inc., Neuropace, Inc., Nevro Corp. and is on the advisory board for Micro Systems Engineering, Inc.

ORCiD: 0000-0002-3954-2929


Andrew J. Ringer, MD

Andrew J. Ringer, MDis a board-certified neurosurgeon with the Mayfield Clinic and the UC Neuroscience Institute in Cincinnati, Ohio. He is a professor of neurosurgery and radiology, director of the Division of Cerebrovascular Surgery, and director of the Endovascular Laboratory at the University of Cincinnati College of Medicine. He is also director of the Division of Neurosurgery and the Graduate Education Program in Neurological Surgery at Good Samaritan Hospital, Cincinnati.

Dr Ringer completed his undergraduate degree from Cornell University and his medical degree from the University of Illinois College of Medicine. He completed an internship in general surgery and residency in neurosurgery at the University of Cincinnati College of Medicine, as well as a fellowship in endovascular surgery at the University of Buffalo.

Dr Ringer's areas of expertise include endovascular coiling and surgical clipping of aneurysms, embolization of tumors and vascular malformations, angioplasty and stenting for intracranial artery stenosis and stroke, arteriovenous malformation embolization and surgery, carotid stenting and endarterectomy, kyphoplasty for spinal fractures, and Chiari malformations. He is a professional member of the American Association of Neurological Surgeons, the Congress of Neurological Surgeons, the American Medical Association, the Society of NeuroInterventional Surgery, the Endovascular Neurosurgery Research Group, and the Frank H. Mayfield Society.

Dr Ringer has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.


Amit M. Saindane, MD

Amit M. Saindane, MD, is an associate professor in the department of radiology and imaging sciences at the Emory University School of Medicine in Atlanta, Georgia. He received his BA in biology and psychology from The Johns Hopkins University in Baltimore, Maryland, in 1998, followed by his MD from the University of Pennsylvania School of Medicine in Philadelphia, Pennsylvania, in 2002. After an internship year at Presbyterian Medical Center in Philadelphia, he completed both his diagnostic radiology residency and neuroradiology fellowship at New York University. He joined the faculty at Emory University School of Medicine in 2008, where he currently serves as the director of the Division of Neuroradiology, Chair of the MRI Quality and Safety committee, and associate director of clinical affairs for the department. Dr Saindane’s clinical interests include applications of advanced MRI techniques for neurological and neurosurgical diseases. His research interests include noninvasive imaging assessment of intracranial pressure disorders. He is an active member in the American Society of Neuroradiology, American College of Radiology, and Southeastern Neuroradiological Society, and is a reviewer for numerous radiology publications.

Dr Saindane has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.

ORCiD: 0000-0002-2903-3995


Dr David Schiff

Dr David Schiff. Dr Schiff received his BA and MD from Harvard, completed internship at the Brigham and Women’s Hospital, and did his Neurology residency in the Harvard-Longwood Neurology Training Program. After completing Neuro-Oncology fellowships at Memorial Sloan-Kettering Cancer Center and Mayo Clinic, he joined the Mayo faculty. He spent five years on staff at the University of Pittsburgh before moving to University of Virginia to develop their medical Neuro-Oncology program. He now serves as the Harrison Distinguished Teaching Professor of Neurology, Neurological Surgery, and Medicine.

He has published more than 150 peer-reviewed manuscripts, many relating to brain tumor clinical trials, as well as several textbooks and almost 100 chapters. He is an Associate Editor for Neuro-Oncology, sits on the editorial board for Neurology, and serves on the International Advisory Board for Lancet Oncology.

Dr Schiff serves on DSMCs for Orbus (eflornithine) and Monteris (LITT for glioblastoma). He receives royalties from UpToDate.

ORCiD: 0000-0002-1896-2502


Dr Michael Schlüssel

Dr Michael Schlüssel graduated with a BSc in nutrition from the Federal University of Rio de Janeiro in 2003, followed by an MSc (2006) and PhD (2010) at the same institution; both focused on epidemiology with a strong component of statistics. His background as a researcher includes collaborations with several universities and research centers worldwide, focusing mainly on the data analysis of large population-based epidemiological studies. Michael joined the Centre for Statistics in Medicine (CSM) in 2014 to work as a medical statistician within the Oxford Clinical Trials Research Unit (OCTRU). In his current role, Michael is mainly involved with the planning, conduction, and analysis of randomized clinical trials of non-pharmacological interventions. Michael is also involved with systematic literature reviews and meta-analyses and the development and validation of prognostic models, and he is a lecturer in several courses offered by CSM, OCTRU, and the EQUATOR Network. In 2015, Michael became a fellow of the UK EQUATOR Centre, with the aim of developing and applying strategies to improve medical research methods.

Dr Schlüssel is 100% funded by a grant from the Cancer Research UK

ORCiD: 0000-0002-1711-9310


Dave Segar

Dave Segar is a PGY-5 resident in the Brigham and Women’s & Boston Children’s neurosurgery residency, pursuing a career in functional neurosurgery and epilepsy. Originally from Northern California, Dave obtained both his undergraduate and medical training at Brown University, and now works as a visiting scientist at both MIT and Brown. His clinical and research goals align around developing and improving translational technologies to improve outcomes for patients with intractable epilepsy, movement disorders, psychiatric diseases and brain tumors, with a particular focus on advancing brain stimulation and improving stereotactic procedures.

ORCiD: 0000-0001-9369-1856


Dr Kevin Sheth

Dr Kevin Sheth graduated from Johns Hopkins University and University of Pennsylvania School of Medicine. He was a neurology resident and chief resident at Partners Neurology (Massachusetts General and Brigham & Women's Hospitals). After a fellowship in vascular neurology and neuro-critical care at Harvard, he was appointed the first neurology trained neuro-intensivist at the University of Maryland and R Adams Cowley Shock Trauma Center. He subsequently moved to Yale as the founding chief of the Division of Neurocritical Care and Emergency Neurology and Chief of Clinical Research for the Department of Neurology. Dr Sheth is also the fellowship director in neurocritical care at Yale New Haven Hospital. His interests are in the advancement of therapies and care of patients with devastating acute neurological syndromes, especially those complicated by brain swelling, ischemia and hemorrhage. He is a nationally recognized clinical and translational scientist and has directed a number of multicenter studies testing novel therapies. His research group also develops novel imaging and serum based biomarkers for the neuro-ICU and furthers understanding of prognosis formation. He is the winner of the prestigious Robert Siekert Award from the American Heart Association, and his research has been supported by the NIH, American Academy of Neurology, American Heart Association, US Army, and the Passano Foundation. Dr Sheth has served on study sections for NIH and NASA and is a member of the AHA Stroke Get With the Guidelines Science Executive Committee. He is the co-chair of several national working groups developing guidelines in malignant infarction and serves on several editorial boards including Neurosurgery, Stroke and Neurocritical Care. He has published over 60 papers in critical care neurology and lectured internationally.

Dr Sheth receives research support from AHA and NIH; Grant support from BARD, Novartis, Biogen, Hyperfine

ORCiD: 0000-0003-2003-5473


Hui-Kuo G. Shu, MD, PhD

Hui-Kuo G. Shu, MD, PhD, is a professor in the Department of Radiation Oncology at Emory University. He received his BA in biology at Washington University in St. Louis, MO, in 1986 and MD/PhD in molecular biology at Case Western Reserve University in Cleveland, OH, in 1993. His training included completion of an internship in Internal Medicine at University Hospitals of Cleveland in 1994 and residency in Radiation Oncology at the University of California, San Francisco in 1999. During his time in San Francisco, he also completed a two year research fellowship at the Brain Tumor Research Center at UCSF. He was appointed to the Radiation Oncology faculty at the University of Pennsylvania as a physician-scientist where he remained until he was recruited to join the Department of Radiation Oncology at Emory University in 2005.

Dr Shu specializes in the treatment of CNS malignancies with radiation in adults and children and has published extensively in these areas. He is actively involved many brain tumor clinical trials including as PI for investigator-initiated trials examining a novel histone deacetylase inhibitor for glioblastoma therapy and innovative use of volumetric modulated arc therapy for treatment of brain metastasis. Overall, he has published, as lead/senior author or co-author, more than 100 peer-reviewed manuscripts and 120 abstracts presented at national or international meetings. His most recent research interests have been in the development of spectroscopic magnetic resonance imaging (sMRI) for use in glioblastoma imaging with particular focus on its use to better guide radiation treatment planning for disease that may otherwise not be appreciated on standard MRI sequences. He is co-PI of the Emory Brain Tumor Imaging team that is funded by the National Institutes of Health (NIH) as a U01 to develop sMRI for glioblastoma imaging as one of approximately 25 teams that make up the National Cancer Institute (NCI) Quantitative Imaging Network (QIN). He also has active funding in the form of an R01 from the NCI to pilot use of dose escalation for glioblastoma guided by sMRI. He serves as co-Chair of the NCI – Quantitative Imaging in Radiation Therapy (QIRT) Working Group, a group dedicated to promoting use of quantitative imaging in radiation oncology through collaboration, since its inception in 2017. He is also active in many professional/scientific societies including the American Society for Therapeutic Radiology and Oncology (ASTRO), the Radiological Society of North America (RSNA), the Society for Neuro-Oncology (SNO), among others.

Dr Shu owns stock in the following companies: Akebia Therapeutics Inc. and Medtronic PLC. He has also received honorariums from Varian Medical Systems for speaking on the clinical utility of Velocity AI, a Varian imaging analysis interface.

ORCiD: 0000-0002-4060-0874


Dr Rushna Ali

Dr Rushna Ali was born in Karachi, Pakistan and is a graduate of the Aga Khan University.

Her neurosurgical residency was at Henry Ford Hospital in Detroit, MI, and she completed her training with a fellowship in Epilepsy and Functional Neurosurgery from Vanderbilt University in Nashville, TN. She is currently a Clinical Instructor at Michigan State University and Director of Restorative and Functional Neurosurgery at Spectrum Health Medical Group in Grand Rapids, MI.

Dr Ali has a special interest in extratemporal epilepsy and is currently working on developing a surgical decision making algorithm. She is also studying the role of neuromodulation in stroke recovery.

Dr Ali is a member of the AANS, CNS, WSSFN, NANS and ASSFN.


Lubdha M. Shah

Lubdha M. Shah is Associate Professor of Radiology and serves as the director of Advanced Spine Imaging at the University of Utah. She completed her Neuroradiology Fellowship at Duke University Medical Center. Her research interests include clinical application of advanced imaging techniques, including functional MRI (fMRI) and diffusion tensor imaging (DTI) in the brain and spine. Dr Shah has served on the NINDS K-award study section for over 6 years. In addition to reviewing for several Radiology, Neuroradiology, and Neurosurgery journals, she holds the role of a Neuroradiology Panel chair in the American College of Radiology Neuroradiology and has authored Appropriateness Criteria and Practice Parameter guidelines. Dr Shah is currently Vice-President of the American Society of Spine Radiology.

Dr Shah has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.

ORCiD: 0000-0003-1303-3533


Dr Jonathan H. Sherman, MD, FAANS, FACS

Dr Jonathan H. Sherman, MD, FAANS, FACS is a board-certified neurosurgeon specializing in Surgical Neuro-oncology. He obtained his medical degree from the Medical College of Georgia and completed his neurosurgery residency at the University of Virginia.

Following completion of residency, he completed a fellowship in Surgical Neuro-oncology at Memorial Sloan-Kettering Cancer Center. Dr Sherman joined the faculty at The George Washington University Department of Neurosurgery in July 2011 and served as Associate Professor of Neurosurgery as well as the Director of Neuro-surgical Oncology and Stereotactic Radiosurgery. In this effort, he led a multi-disciplinary team and developed a robust translational research program as well as a clinical trials program. He has several clinical research interests in neuro-oncology and has published greater than 100 manuscripts in peer-reviewed journals. He also co-authored the textbook Cold Plasma Plasma Cancer Therapy as well as 15 book chapters. He is also a pioneer in the use of new healthcare innovations such as virtual reality to improve the outcomes of his patients. In addition, Dr Sherman served as mentor and educator to both medical students and residents at The George Washington University His clinical, research and teaching efforts were recognized by leadership at both The George Washington University and The George Washington University Hospital. He was also recognized by his peers as a Washingtonian Top Doctor for the past 5 years.

While at The George Washington University, Dr Sherman established himself as a national and international expert in the treatment of patients with brain and spinal tumors. He is a member of both the American Association of Neurological Surgeons (AANS) and the Congress of Neurological Surgeons (CNS) and has served on the AANS/CNS Joint Tumor Section Executive Committee for the past 6 ½ years. He continues to expand his volunteer work with these organizations and was recently nominated for the Executive Committee for the CNS. Dr Sherman also serves on the International Scientific Committee for the International Workshop on Plasma for Cancer Treatment. He has served as a reviewer for numerous medical journals and currently serves as Academic Editor for the journal PLoS-One and was recently appointed as Associate Editor for Operative Neurosurgery as well as Editor for the newly established Journal of the International Virtual Reality Healthcare Association. He serves as both a Fellow of the American Association of Neurological Surgeons as well as a Fellow of the American College of Surgeons.

Dr Sherman has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.

ORCiD: 0000-0001-9482-3988


Dr Anthony Sin

Dr Anthony Sin is presently Professor, Vice-Chair and Director of Complex Spinal Disorders, Dr Donald and Kathryn Smith Endowed Chair for Department of Neurosurgery in Ochsner-LSU Health in Shreveport, LA.  He completed his undergraduate degree in physics at Johns Hopkins University.  Dr Sin received medical doctorate from Emory University School of Medicine. He completed an internship in general surgery at SUNY-Stone Brook and a residency in neurological surgery at LSUHSC-Shreveport. He has also spent an additional post-graduate year studying minimally invasive spine surgery under Dr Kevin Foley at University of Tennessee in Memphis.  

His clinical interests include pediatric and adult deformity disorders, degenerative, trauma, craniocervical junctional problems, spinal oncology, and revision surgeries. Dr Sin has been treating pediatric patients with congenital and idiopathic spinal deformity problems, early onset and idiopathic scoliosis, Scheuermann’s kyphosis, high-grade spondylolisthesis through Shriners Hospital for Children in Shreveport since 2011 as their primary spine surgeon. 

He is an active member for AANS, CNS, Spine section of AANS/CNS, and executive committee for the Society of University Neurosurgeons, Louisiana Neurosurgical Society. He also serves as an associate editor for Neurosurgery and ad hoc reviewer for World Neurosurgery and Neurospine.

Dr Sin has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.

ORCiD: 0000-0002-4234-0797


Andrew E. Sloan, MD, FAANS, FACS

Andrew E. Sloan, MD, FAANS, FACS, is a neurosurgeon, physician-scientist, and educator whose clinical and research interests focus on the biology and treatment of tumors of the brain and spine. After graduating Yale University with a degree in biology (magna cum laude) and receiving his MD from Harvard Medical School, Dr Sloan served his internship in general surgery and his neurosurgical residency at UCLA under Dr Donald P. Becker, followed by a fellowship in neurosurgical oncology at the MD Anderson Cancer Center in Houston under Dr Raymond Sawaya. He has been recognized by his peers as one of the "Best Doctors in America" since 2003, and as one of the "Top Surgeons in America" since 2007. In 2014 he was elected president of the Ohio State Neurosurgical Society (OSNS). His research on glioma vaccines and glioma stem cells has been funded by NIH, NCI, the Ohio Third Frontier organization, the American Society of Clinical Oncology (ASCO), the American Brain Tumor Association (ABTA), the Adult Brain Tumor Consortium (ABTC), Howard Hughes Medical Institute (HHMI), and other national organizations, and he is currently helping to develop a new generation of neurosurgical simulators. He has over 135 publications in peer-reviewed journals, as well as numerous editorials, reviews, and book chapters, and more than 525 invited presentations and 4 patents and INDs. He serves on the editorial board of several neurosurgical and scientific journals and is active in national neurosurgical organizations. Dr Sloan is currently a professor and vice-chair of neurosurgery at CWRU with joint appointments in Pathology and the Center for Translational Neuroscience. He holds the Peter D. Cristal Endowed Chair in Neurosurgery at University Hospitals and serves as the director of the Brain Tumor & Neuro-Oncology Program at the Neurological Institute and Seidman Cancer Center as well as the Case Western Reserve University School of Medicine.

Dr Sloan provide research support to Lentigen, Merck, NIH/NCI. He is a consultant for Medtronic (Visualase), Monteris Medical, Surgical Theater (and has ownership in Surgical Theater) and patents on FDA IND 24,009 for use of 5-ALA in intra-operative Imaging, US Patent on DVI, US Patent on PTPu for intra-operative imaging.


Brandon Smith

Brandon Smith is currently a 3rd year medical student at King’s College London with student with a deep-seated interest in neurosurgery, preparing to pursue an academic neurosurgical career path in the future. He has special interests in the fields of medical technology & education, working on a number of web-based education resources, and is keen to pursue a surgical PhD studentship in the coming years.

Disclosures: Brandon Smith has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.

ORCiD: 0000-0001-8471-1368


Dr Edward Smith

Dr Edward Smith received his undergraduate degree from Dartmouth College and his medical degree from Columbia University. He completed his internship at Massachusetts General Hospital, residency in neurosurgery at Massachusetts General Hospital, and a fellowship at Boston Children's Hospital, where he currently practices as pediatric neurosurgeon.

Dr Smith focuses his practice on treating patients with cerebrovascular disease and brain tumors, with a particular focus on moyamoya syndrome, arteriovenous malformations, and skull base tumors.

Dr Smith has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.


Dr Justin Smith

Dr Justin Smith completed the combined MD-PhD program at Mayo Clinic in Rochester, MN and a neurosurgery residency at the University of California, San Francisco. He has completed spine surgery fellowships in the areas of adult and pediatric spinal deformity (University of Virginia) and minimally invasive spine surgery (Northwestern University). He is currently professor in the Department of Neurological Surgery at the University of Virginia. He serves as faculty for neurosurgery residents and fellows and as co-director of the spine fellowship program and co-director of the UVA Spine Center.

Dr Smith's practice is predominantly spinal surgery and includes cervical and thoracolumbar deformity reconstruction, oncology, trauma, degenerative disease, and complex revision surgery. He is an active member in multiple societies, including the Scoliosis Research Society and Cervical Spine Research Society, and is a founding member of the International Spine Study Group (ISSG). His research interests focus on clinical outcomes of spinal surgery, and he has published extensively in this and other areas, with more than 250 peer-reviewed manuscripts and more than 750 presented abstracts at national and international meetings.

Dr Smith consultant, royalties, honoraria for teaching with Zimmer Biomet, is a consultant, receives honoraria for teaching with Nuvasive and K2M, is a consultant for AlloSource, Cerapedics, receives research funding with DePuy Synthes/ISSGF, receives research funding, fellowship support for AOSpine, fellowship support with NREF, is on the ISSGF: executive committee, is on the Cervical Spine Research Society (CSRS): executive committee, and is on the Neurosurgery Editorial Board.


Dr Zachary A. Smith

Dr Zachary A. Smithis a fellowship trained, board certified neurosurgeon with fellowship training in minimally invasive and complex spine surgery.  Is the an Associate Professor of Neurosurgery at Northwestern and the Director of Spinal Research. He has a strong interest and experience in the treatment of cervical spine disease and tumors of the spine. In addition, he is the principal investigator a NIH-funded prospective study (K23) that evaluates biomarkers of spinal injury in patients with cervical spine compression. This study is a collaboration between Northwestern Medicine, the Shirley Ryan Ability Lab and the Northwestern Neuroimaging Institute. Dr Smith graduated as a Presidential Scholar from Dartmouth College (Hanover, NH). He obtained his medical and neurosurgical training at UCLA and fellowship at Northwestern. He is the recipient of the CNS Spine Fellowship award and the AANS/CNS Spine Section Apfelbaum Awards. Dr Smith has published greater than 200 combined peer-reviewed articles, book chapters, and editorials. He has additionally presented > 100 combined talks and abstracts at national and international conferences. He has been an editor on two books that focused on minimally invasive spine techniques. He has published in multiple journals including Nature, Neurosurgery, Journal of Neurosurgery, Neurology, and the Journal of NeuroOncology. 

Dr Smith receives a K23 grant and NIN-NINDS.


Mariano Socolovsky, MD, PhD

Mariano Socolovsky, MD, PhD, was born in Buenos Aires, Argentina, in 1971. He completed his medical education at the University of Buenos Aires School of Medicine in 1994. He was trained at the Department of Neurosurgery at the Hospital de Clínicas, University of Buenos Aires School of Medicine, Buenos Aires, Argentina, and finished his residency program in 2000. He obtained his board certification as neurosurgeon in 2001 and specialized in peripheral nerve & brachial plexus surgery. He currently chairs the Peripheral Nerve Surgery Program at the Department of Neurosurgery, Hospital de Clinicas, Buenos Aires. Dr Socolovsky and his team surgically treat more than 400 patients suffering peripheral nerve, brachial plexus, lumbosacral plexus, and facial nerve injuries per year.

Dr Socolovsky is past-chair of the Society of Neurosurgery of Buenos Aires and currently serves as member of the executive committee of the Argentine Association of Neurosurgery. He was elected as chairman of the Peripheral Nerve Committee of the World Federation of Neurosurgical Societies (WFNS) for the period 2013-2017, as an international member of the AANS and CNS, and also member of the Sunderland Society & NervClub. He has authored 7 books, more than 40 book chapters, and 35 publications indexed in Pubmed. He is currently co-director of the Argentine Journal of Neurosurgery and editor of Chyld's Nervous System.

Dr Socolovsky has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.

ORCiD: 0000-0002-0667-3463


Maria Vittoria Spampinato, MD

Maria Vittoria Spampinato, MD, is a professor of radiology and the director of the Neuroradiology Division at the Medical University of South Carolina in Charleston, South Carolina. Dr Spampinato completed a diagnostic radiology residency at the Universita Cattolica del Sacro Cuore, Rome, Italy. Following a research fellowship at the National Institute for Neurological Diseases and Stroke, she completed a neuroradiology fellowship at the University of North Carolina. Dr Spampinato joined the radiology faculty at the Medical University of South Carolina in 2005 and was appointed director of neuroradiology at MUSC in 2013. She is on the editorial board of the American Journal of Neuroradiology and of theNeurovascular Imaging Journal. Her research interests include the use of structural and diffusion MRI in stroke outcome prediction and in neurodegenerative disorders.

Dr Spampinato does not have any personal or institutional financial interest in drugs, materials, or device. She is an investigator in two research grants sponsored by Bracco and has received salary support in the past 12 months.

ORCiD: 0000-0002-2040-1894


Robert J. Spinner, MD

Robert J. Spinner, MD, is the Burton M. Onofrio, MD Professor of Neurologic Surgery at the Mayo Clinic where he is also Professor of Orthopedics and Anatomy. He is chair of the Academic Appointments and Promotions Committee at Mayo. He is board certified in both orthopedics and neurosurgery. His clinical practice is limited to peripheral nerve surgery.

He completed full residency programs in orthopedics (Duke University) and neurosurgery (Mayo Clinic) and a 1 year peripheral nerve fellowship with David Kline and a 6 month traveling fellowship to several international centers as a CNS Cushing Fellow. He recently served as the President of the American Society for Peripheral Nerve.

Disclosures: Dr Spinner is a consultant for Mayo Medical Ventures and J&J.

ORCiD: 0000-0003-0443-7763


Dr Martina Stippler

Dr Martina Stippler is Director of Neurotrauma at Beth Israel Deaconess Medical Center. She completed her neurosurgery Training at the University of Pittsburgh Medical Center. Her has busy complex spine and endoscopic pituitary practice. Her research interests are in multimodal TBI management, triage of mild TBI and end of life discussion and goal of care discussion in the urgent setting. She has participated in many landmark TBI studies such as PROTECT, RESCUE acute SDH trial and coming soon BOOST III. She is member at large of the AANS/CNS section of Neurotrauma and Chair Elect of Women in Neurosurgery and on the CSN EC.

Disclosures: Dr Stippler has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.

ORCiD: 0000-0003-3284-7639


Dr Rafael Tamargo

Dr Rafael Tamargo is currently the Walter E. Dandy Professor of Neurosurgery and director of the Division of Cerebrovascular Neurosurgery at the Johns Hopkins University School of Medicine. He is also vice-chairman of the Department of Neurosurgery at Johns Hopkins and has a secondary appointment as professor of otolaryngology–head and neck surgery, also at Johns Hopkins. Dr Tamargo specializes in the microsurgical treatment of aneurysms, arteriovenous malformations, arteriovenous fistulas, and moyamoya disease. He also specializes in the microsurgical and radiosurgical treatment of skull base lesions, particularly vestibular schwannomas.

Dr Tamargo was born in Havana, Cuba, and grew up in Central America and the Caribbean. He graduated from Princeton University magna cum laude and earned his medical doctorate from the Columbia University College of Physicians and Surgeons. He completed a general surgery internship at the Columbia-Presbyterian Medical Center and a neurosurgery residency at the Johns Hopkins Hospital.

Dr Tamargo has published more than 200 peer-reviewed articles and 30 chapters, is co-editor of 3 books, has reviewed for more than 15 major medical journals over the past 16 years, and has given over 150 lectures nationally and internationally. Currently, his academic work is associated with a Hirsch Index of 55 (Google Scholar). His basic science research has focused on endothelial cell-leukocyte interactions after subarachnoid hemorrhage and polymeric controlled drug delivery. His clinical research has focused on microsurgical techniques, epidemiological features, and outcomes of aneurysms, arteriovenous malformations, vestibular schwannomas, and skull base malignancies. Dr Tamargo's neurosurgical leadership and expertise have been recognized by his memberships in the 3 selective North American neurosurgical societies, namely the American Academy of Neurological Surgery, the Neurosurgical Society of America, and the Society of Neurological Surgeons. He serves on the Medical Advisory Boards of the Brain Aneurysm Foundation (Hanover, MA) and the Acoustic Neuroma Association (Cumming, GA)

Dr Tamargo has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.

ORCiD: 0000-0003-0923-1625


Philip Theodosopoulos

Philip Theodosopoulos was born in Thessaloniki, Greece, on September 10, 1970. He received a bachelor degree in biology and in political science from the Massachusetts Institute of Technology in 1991 and 1992 and his MD from Stanford University in 1996. Under the tutelage of Charles Wilson and Mitchel Berger, he completed his neurosurgical residency at the University of California San Francisco and then completed a fellowship in cerebrovascular and skull base surgery at the Brigham and Women's Hospital, Harvard University, under the direction of Arthur Day. He is board certified in neurological surgery.

Following his postgraduate training, he joined the faculty of the Department of Neurological Surgery at the University of Cincinnati, where he served as director of skull base surgery and residency program director from 2008 to 2013.

Dr Theodosopoulos is currently the Khatib Professor, director of skull base surgery, and vice chairman of the Department of Neurosurgery at the University of California, San Francisco. Dr Theodosopoulos also serves as the director of cranial programs and is a member of the Residency Education Committee.

Dr Theodosopoulos is interested in brain tumor surgery, with a specific focus on skull base lesions and endoscopy. His research interests center on anatomy and its role in the development of minimally invasive surgical approaches, as well as on outcomes research in neurosurgery. He is the author of over forty publications. He is married to Dr Josefa Rangel, an integrative medicine physician. They have three daughters, Petra, Sky, and Tèa.

Dr Theodosopoulos has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.


Dr Jasmine Thum

Dr Jasmine Thum is a PGY 6 neurosurgery resident at UCLA, originally from Austin, TX. She went to the University of Southern California for her BS and MS degrees in biomedical engineering/ neuroengineering. She then attended the Health Sciences and Technology program at Harvard Medical School / Massachusetts Institute of Technology. She is interested in functional neurosurgery and peripheral nerve, and engages in neurophysiology research on networks for consciousness.


Krystal Tomei, MD, MPH

Krystal Tomei, MD, MPH, is a pediatric neurosurgeon in the Division of Neurosurgery at University Hospitals Case Medical Center. She is an assistant professor of neurosurgery, Case Western Reserve University School of Medicine.

Dr Tomei is board eligible in neurosurgery. Her special interests include congenital spinal disorders and spina bifida, craniosynostosis, pediatric brain tumors, traumatic brain injury in children, and Chiari malformations. She was named to the UH Case Medical Center staff in 2014.

Dr Tomei earned a bachelor's degree in chemistry with honors from the University of Florida, Gainesville, FL., and was elected to Phi Beta Kappa. She earned her doctorate in medicine from the University of Florida College of Medicine, and a Master's of Public Health from Harvard School of Public Health, Boston, MA. Dr Tomei completed her residency in neurosurgery at the University of Medicine and Dentistry of New Jersey – New Jersey Medical School, Newark, NJ., and a fellowship in pediatric neurosurgery at The Barrow Neurological Institute at Phoenix Children's Hospital, Phoenix, AZ.

She has coauthored more than a dozen papers and editorials in medical journals and contributed to 2 textbook chapters.

Dr Tomei's professional memberships include the American Medical Association, American Association of Neurological Surgeons, Congress of Neurological Surgeons, and American College of Surgeons. She currently serves as chair of the AANS Young Neurosurgeons Committee and the CNS Resident Committee. She is editor of Clinical Neurosurgery.

Dr Tomei has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.

ORCiD: 0000-0001-8601-8938


Dr Eve Tsai, MD, PhD, CIP, FRCSC

Dr Eve Tsai, MD, PhD, CIP, FRCSC, gained early acceptance into medical school and obtained her medical degree from the University of Toronto. She then completed her neurosurgery residency training at the University of Toronto. During her residency, she completed a PhD in spinal cord repair. Dr Tsai then obtained subspecialty training in spine surgery and completed a pine Fellowship at The Cleveland Clinic. She has won numerous clinical, research, teaching, and humanitarian awards.

In both 2011, 2012 and 2014, Dr Tsai was selected by a committee as one of the Top 25 Women of Influence by Women of Influence Magazine (the only woman who has had the honor of winning thrice). She was also chosen as the winner of the Health Section Category and is the only woman to have won the cover of the magazine for 2 years in a row. The cover was selected by the most online votes (Women of Influence Magazine) In 2010, she won Canada's Top 40 Under 40 AwardTM, which honors achievement for vision and leadership, innovation and achievement, impact, growth/development strategy, and community involvement and contribution. She has also won the AANS Young Clinician Investigator Award in 2008.

Dr Tsai is the Suruchi Bhargava Chair in Spinal Cord and Brain Regeneration at the Ottawa Hospital. Her clinical practice focuses on all types of spine and spinal cord diseases such as: spinal cord injury, spinal cord and spine tumors, syringomyelia, and myelopathy. Her research focuses on spinal cord repair strategies, axonal regeneration, MRI imaging of spinal cord tracts in humans and animals, and clinical outcomes after spine surgery.

Dr Tsai is a consultant for Depuy Synthes.

ORCiD: 0000-0002-8152-349X


Dr Chia-Lin Tseng

Dr Chia-Lin Tseng is an Assistant Professor at the University of Toronto, Department of Radiation Oncology and a staff Radiation Oncologist at Sunnybrook Health Sciences Centre, Odette Cancer Centre. He earned his medical degree from McGill University in Montreal, Canada, and completed his radiation oncology residency training at the University of Toronto. He subsequently completed a fellowship in CNS radiation oncology, specializing in brain radiosurgery and spine stereotactic body radiotherapy (SBRT), as well as in brachytherapy at Sunnybrook Health Sciences Centre in Toronto, Canada. In addition, he was a research fellow in MR-guided radiotherapy at University Medical Center Utrecht, Utrecht, Netherlands. He is board-certified by both The American Board of Radiology and The Royal College of Physicians and Surgeons of Canada in Radiation Oncology.

Dr Tseng’s clinical practice includes primary and metastatic tumors of the CNS, as well as functional indications for stereotactic radiosurgery (SRS). His research focuses on stereotactic radiation for brain and spine metastases. He has extensive interests in MR-guided radiotherapy, and its applications in imaging-based biomarkers and individualized adaptive radiation.

Dr Tseng receives travel accommodations/expenses & past educational seminars by Elekta; he also belongs to the Elekta MR Linac Research Consortium.

ORCiD: 0000-0002-3700-0886


Luis M. Tumialán

Luis M. Tumialán graduated from Georgetown University School of Medicine. Upon completion of his internship at the Naval Medical Center San Diego, he began his operational tours in the Navy. Following 6 months of submarine school in Groton, Connecticut and dive school at the Naval Diving and Salvage Training Center in Panama City, Florida, he received orders to serve as the Diving Medical Officer (DMO) assigned to Naval Special Warfare Unit One in Guam. After September 11th, 2001, Dr Tumialán spent the next 2 years supporting missions for various Navy SEAL platoons around Southeast Asia. He received a Naval and Marine Corps Commendation Medal for service in support of Operation Enduring Freedom and a Navy Humanitarian Medal for the search and maritime rescue of a foreign national.

Once he returned to the mainland, Dr Tumialán started his neurosurgery training at Emory University School of Medicine. After the completion of his residency, he returned to the Naval Medical Center in San Diego. He joined Barrow Brain and Spine, where he serves as the director of minimally invasive spine surgery. Dr Tumialán's main interests are in minimally invasive surgery and motion preservation surgery as well as developing techniques for the next generation of spinal surgery.

Dr Tumialán is a consultant for Medtronic and Zimmer-Biomet. He has an investment in LessRay which was acquired by NuVasive.


Staša Tumpa

Staša Tumpa is a second year Graduate Medicine student at the University of Cambridge. She was awarded BSc(Hons) in Neuroscience from University of St Andrews and MSc in Clinical Neuroscience from UCL. Her particular interests are in pediatric neurosurgery and epilepsy surgery. Outside of medicine she does fencing for Cambridge University first team.

Disclosures: Ms Tumpa has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.

ORCiD: 0000-0003-0979-5113


Jamie S. Ullman, MD, FACS

Jamie S. Ullman, MD, FACS is associate professor in the Department of Neurosurgery of the Hofstra Northwell School of Medicine and is the director of neurotrauma for North Shore University Hospital in Manhasset, New York and the Northwell Health System. Her clinical interests are in traumatic brain injury treatment, critical care, and public health issues regarding pedestrian injury. In addition, she practices as a general neurosurgeon with interest in the surgical management of brain tumors, degenerative and traumatic spine disease, trigeminal neuralgia, and normal pressure hydrocephalus.

Born in Brooklyn, New York, Dr Ullman was raised in New Jersey and attended Rutgers University, where she was inducted into the Phi Beta Kappa honor society. She graduated with a Bachelor of Arts degree with honors in zoology. She then attended the University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School. Postgraduate training took her back to New York, where she completed her neurosurgery residency at the Mount Sinai School of Medicine with fellowship training in neurotrauma at the University of Maryland, Shock Trauma Center, and neurosurgery critical care at the Mount Sinai School of Medicine. She remained at Mount Sinai in the Department of Neurosurgery, serving as the director of neurosurgery at Elmhurst Hospital Center, Mount Sinai's primary teaching affiliate, for 17 years prior to moving to the Northwell Health System.

Dr Ullman is a past president of Women in Neurosurgery. She served as vice president of the Congress of Neurological Surgeons (CNS), an 8000-member national and international neurosurgical society; she is the first woman to be elected to an officer's position in the organization's 61-year history. Dr Ullman is also past chair of the AANS/CNS Section on Neurotrauma and Critical Care, having been a member of this executive committee for 19 years, and served as an ex-officio member of the American Association of Neurological Surgeons' Board of Directors. In addition, Dr Ullman is a fellow of the American College of Surgeons (ACS) and served as the chair of the neurosurgery subspecialty member of the prestigious ACS Committee on Trauma. She is appointed by the Commissioner of Health to serve as the neurosurgeon member of the New York State Trauma Advisory Committee, as well as serving on the New York City Regional Trauma Advisory Committee. Dr Ullman has, on many occasions, presented neurotrauma topics and papers both regionally and nationally and serves as a reviewer for the journals Neurosurgery, World Neurosurgery, and Surgical Neurology. In addition to book chapters and peer-reviewed papers, she is a co-author on the renowned 3rd and upcoming 4th edition of the Brain Trauma Foundation's Guidelines for the Management of Severe Traumatic Brain Injury and co-edited the Atlas of Emergency Neurosurgery, published by Thieme in 2015.

Dr Ullman has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.

ORCiD: 0000-0001-6082-9222


Juan S. Uribe

Juan S. Uribe was born in Boston, MA. Dr Uribe completed double neurosurgical residency training at the Universidad de Antioquia in Colombia and University of South Florida in Tampa, FL. Given his interest in the spine, Dr Uribe completed a clinical complex spine fellowship at the University of Miami and the Miami Project to Cure Paralysis. He is currently the chief of spinal disorders as well as the vice chairman of neurosurgery at Barrow Neurological Institute in Phoenix, AZ.

With over two decades of research experience, Dr Uribe leads interdisciplinary, collaborative teams to achieve novel research discoveries. He serves as the Volker K.H. Sonntag Chair of Spine Research. His research focus is advancing the technologies and techniques in minimally invasive surgery. Additional research interests include anatomical, biomechanical, and clinical studies of applying minimally invasive spine surgery to complex traumatic injuries, tumors, and degenerative diseases.

Aligning with his clinical endeavors and research pursuits, Dr Uribe has lectured extensively on minimally invasive spine surgery at both national and international conferences. Dr Uribe has expanded the use of minimally invasive techniques in complex spine pathologies and has trained spine surgeons in six continents. His publication record includes book chapters and over one hundred peer reviewed journal articles.

Dr Uribe consultant for NuVasive, Inc., Misonix, and SI-Bone. NuVasive Inc., he provides research support and receives stock options.


Jorge F. Urquiaga

Jorge F. Urquiaga, MD is a PGY3 Neurosurgery resident at Saint Louis University, originally from Lima, Peru. After completing his medical training at Universidad Peruana Cayetano Heredia and working one year as a physician for the Peruvian Army,  he moved to St. Louis, Missouri and spent one year as a Skull Base and Cerebrovascular Research Fellow at Saint Louis University Department of Neurosurgery. Dr. Urquiaga then accepted a 2-year position as a Pre-Residency Clinical Fellow at the same institution prior to beginning his training as a Neurosurgery resident. Dr. Urquiaga is interested in spinal MIS and deformity surgery. He is also committed to leadership and organizational development, and he currently serves as president of the Saint Louis University Resident and Fellow Association.

ORCID ID: 0000-0001-7091-093X


John H. Shin, MD

John H. Shin, MD is an attending neurosurgeon and Director of Spine Oncology & Spinal Deformity Surgery at the Massachusetts General Hospital in Boston. He is the Director of Spine Research and Associate Professor of Harvard Medical School. Dr Shin completed his neurosurgery residency training at the University of Illinois at Chicago and complex spine fellowship at the Cleveland Clinic. He currently serves as Co-chair of the Media committee for the AANS/CNS Spine Section.

Dr Shin is a consultant for Carbofix, Depuy, Medtronic, and Nuvasive.

ORCiD: 0000-0001-7490-8108


Dr Erol Veznedaroglu

Dr Erol Veznedaroglu is director of the Drexel Neurosciences Institute (DNI) and chairman of the Department of Neurosurgery at Drexel University College of Medicine.

Dr Vez, as he is known, leads a team of some of the nation's most experienced neurosurgeons specializing in vascular, tumor, spine, and functional neurosurgery—as well as a consortium of neuroscience physicians providing subspecialty neurology and comprehensive pain management. His leadership has created a network of neuroscience institutes at partner healthcare systems in New Jersey and Pennsylvania. DNI's neurosurgeons treat patients transferred from more than 100 healthcare facilities. Dr Vez is one of a select number of neurosurgeons in the country trained in both traditional open and minimally invasive cerebrovascular/endovascular neurosurgical approaches.

Dr Vez launched a neurosciences institute in 2009 at what was formerly a community hospital in New Jersey after serving as director of the Division of Cerebrovascular and Endovascular Neurosurgery at Thomas Jefferson University Hospital. Within 2 years of inception, this institute was performing more complex brain and aneurysm procedures than any other hospital in the state. He also conceptualized, developed, and successfully implemented the world's first dedicated Neuro ED to streamline and expedite treatment for patients with brain-related, time-sensitive conditions.

Dr Vez directed the endovascular/cerebrovascular neurosurgery fellowship program at Thomas Jefferson University Hospital, where he completed his fellowship training in cerebrovascular/neurointerventional neurosurgery and neuro-critical care. He earned his medical degree in 1996 from the State University of New York at Buffalo School of Medicine.

Dr Vez has impressive accomplishments in research and design. He designed and invented coils for the treatment of wide-necked aneurysms and was the first neurosurgeon in the country to use the Trevo® Pro Retriever, following approval by the FDA, for the treatment of stroke. He was able to obtain approval for the nation's only protocol of its kind for the delivery of an intra-arterial chemotherapeutic agent directly to the site of a particularly insidious type of brain tumor, glioblastome multiforme (GBM), thus increasing the effectiveness of this agent and eliminating the side effects related to the traditional intravenous delivery method. He was also the first doctor in the mid-Atlantic region pioneering the use of numerous devices, including the Wingspan stent system, the first FDA-approved stent used to open clogged arteries in the brain, the Merci Retriever, the Penumbra device, and the Cordis Enterprise Stent for the treatment of wide necked aneurysms.
In addition to his clinical leadership, Dr Vez is an invited lecturer at conferences both throughout the country and internationally. He has lectured extensively on the treatment of aneurysm, subarachnoid hemorrhage, stroke, and other intracranial vascular disorders.

Dr Vez is the primary investigator of numerous clinical and basic science studies related to cerebrovascular disease and is a nationally recognized academic leader in the area of cerebrovascular care, having written chapters and articles in various publications that are used by neurosurgeons across the country. He has been recognized by both peers and patients as a Top Doc, appearing in SJ Magazine's Top Doc issue multiple times and as part of South Jersey Magazine's Top Docs, as voted by readers. NJ Biz also recognized him as a finalist in the category of Best Physician in its annual Healthcare Heroes awards program.

Dr Veznedaroglu is a consultant for the following: Stryker, Trice and Penumbra.

ORCiD: 0000-0002-7773-9634


Ashwin Viswanathan, MD

Ashwin Viswanathan, MD, is an Associate Professor of Neurosurgery at Baylor College of Medicine, where he is the Director of Functional Neurosurgery. He specializes in ablative and neuromodulatory approaches to treating patients with movement disorders and pain. He research interests include spinal cord pain transmission and electrophysiology of the basal ganglia. He is an active member of the Congress of Neurological Surgeons and the American Society of Stereotactic and Functional Neurosurgery (ASSFN).

Dr Viswanathan has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.

ORCiD: 0000-0002-9602-8563


Beverly C. Walters

Beverly C. Walters is a neurosurgeon and clinical epidemiologist who is retired from a full time clinical practice in general neurosurgery, focusing on spine, brachial plexus, and peripheral nerve, to pursue her interest in applied evidence-based medicine. She is an Adjunct Professor of Neurological Surgery and Director of Clinical Researchin the Division of Neurosurgery at the University of Alabama at Birmingham and Visiting Professor of Neurosurgery at the University of Zagreb, Croatia. She also holds the position of Director of Clinical Research at the Henry Ford Health Sciences Department of Neurosurgery in Detroit. Previously, she held academic appointments that included Clinical Professor of Neurological Surgery at New York University School of Medicine and Adjunct Professor of Surgery at the Uniformed Services University of the Health Sciences in Bethesda, and was also Director of Outcomes Research in the Department of Neurosurgery at Walter Reed Army Medical Center. She was formerly an Associate Professor and the Neurosurgery Residency Program Director at Brown University School of Medicine. Her experience in clinical research involves the design and implementation of randomized controlled trials, case-control studies, meta-analyses, and outcome measure evaluation, and she has written extensively on study design and assessment of the quality of medical literature, including being the author/co-author of eighteen monographs on critical appraisal, as well as editorials and book chapters on methodological and statistical aspects of neurosurgical research. She has extensive experience in survey methodology and has developed a statistical technique for use in generating evidence for use in algorithms when randomized controlled trials cannot be done. She has been a lecturer, tutor, and course designer for several educational programs on critical appraisal of the medical literature for practicing clinicians, graduate students, postgraduate trainees, and medical students. She has published over 230 articles in the medical literature and is the co-editor of the neurosurgical textbook, Evidence-based Neurosurgery.

For many years, Dr Walters was the chairperson of the Practice Guidelines Committee of the American Association of Neurological Surgeons, a member of the Outcomes Committee of the AANS/CNS, and a member of the Committee for the Assessment of Quality of the AANS/CNS. Her guidelines activities have included the development of the Guidelines for the Management of Severe Head Injury, the Guidelines for Prehospital Management of Traumatic Brain Injury, Guidelines for the Surgical Management of Traumatic Brain Injury, Guidelines for Penetrating Brain Injury, Acute Spinal Cord Injury Guidelines, Guidelines for the Treatment of Low Grade Gliomas, Guidelines for the Management of the Neurobehavioral Consequences of Traumatic Brain Injury and the Lumbar Fusion Guidelines. Her work on the Spinal Cord Injury Guidelines was recognized by the United States Congress for its achievement in The Congressional Record, first in 2002 and then again in 2013. She was also honored by the Congress of Neurological Surgeons for her guideline work with their Exceptional and Distinguished Service Award. She was the 2011 recipient of the Anthony Marmarou Lectureship in Neurotrauma at the CNS, and the first recipient of the Haines Family Lectureship in Neurosurgery Clinical Research at the University of Minnesota in 2012. She gives courses on guideline development, and writes frequently on outcome measurement for neurosurgeons. In addition, she has been involved with research on women in medicine and surgery, including undergraduate medical education, and is author or co-author of several publications on this topic, including the Annotated Bibliography of Women in Medicine.

Dr Walters’ company, EBM Advisors, provides medical and clinical epidemiological consulting services to universities and hospitals, as well as medical device and pharmaceutical companies planning clinical trials, analyzing data, and preparing for submissions to the NIH and FDA. EBM Advisors also provides clinical data due diligence services for venture capital firms considering investment in medical device and pharmaceutical companies.

Dr Walters has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.

ORCiD: 0000-0002-5244-4282


Tony J. C. Wang, MD

Tony J. C. Wang, MD, is the Co-Director of the Center for Radiosurgery and an Associate Professor of Radiation Oncology (in Neurological Surgery) at New York Presbyterian/Columbia University Medical Center. He is recognized nationally for his extensive expertise in malignant and benign brain tumors. His research interests are in Gamma Knife stereotactic radiosurgery and brain tumors resulting in over 50 peer-reviewed publications. He has given over 50 invited lectures and visiting professorships nationally and internationally.

He serves on several national and international working groups developing guidelines for brain tumor management and stereotactic radiosurgery. He is an editor for 2 radiation oncology textbooks and a writer for over 15 book chapters. He serves as an Editor of Translational Cancer Research, Associate Editor on the Radiation Oncology Section of Neurosurgery, the official journal of the Congress of Neurological Surgeons, and as a reviewer for International Journal of Radiation Oncology, Biology, and Physics, Practical Radiation Oncology, and Journal of Neuro-Oncology as well as many others.

Dr Wang received his B.A. and MD degrees from University of Missouri Kansas City Medical School, during which time he was also a Clinical Research Training Program Fellow at the National Institutes of Health, Bethesda, Maryland. He received internship training at Flushing Hospital Medical Center. Dr Wang received his radiation oncology training at New York Presbyterian Hospital (Columbia campus), where he was Chief Resident from 2011-2012.

As a member of the Brain Tumor Center and Pituitary Tumor Center at Columbia, Dr Wang is part of a multidisciplinary team that brings expertise from multiple specialties, including neurosurgery, neuro-oncology, neuroradiology, and neuro-endocrinology.

Disclosures: Dr Wang reports personal fees and/or non-financial support from Abbvie, AstraZeneca, Elekta, Merck, Doximity, Wolters Kluwer, and Novocure.

ORCiD: 0000-0001-5809-3025


Dr Songfeng Wang

Dr Songfeng Wang received his PhD in Biostatistics from the University of South Carolina, as well as a MS in Biostatistics from the University of Iowa. Currently he works as a senior quantitative analyst for Wells Fargo bank in the San Francisco bay area. His research interests are in the field of survival analysis and meta-analysis, with experience in both developing novel statistical approaches in these areas as well as their application in the areas of medicine, health sciences and economic research in real world. His research has resulted in publications in leading journals such as JACC and Statistical Methods in Medical Research.

He’s been actively serving as a referee for more than 20 medical and clinical journals, and he is also on the editorial board of several academic journals, including the Journal of American Heart Association. 

Dr Wang has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.


Dr Babu Welch

Dr Babu Welch is originally from the Washington, DC area. After graduation from Morehouse College (Atlanta, GA) he returned to the area to complete his medical (Howard University) and neurosurgical training (George Washington University Medical Center). He subsequently pursued fellowship training in surgical and endovascular treatment of cerebrovascular disease at the UT Southwestern Medical Center (Dallas, TX). As a result of this training he gained proficiency in the treatment of vascular lesions of the brain, carotid arteries, and the acute presentation ischemic stroke using a combination of surgical and endovascular techniques. Dr Welch was recruited to the faculty at UT Southwestern for this expertise. While he maintains an interest in general and skull base neurosurgery, his practice has evolved toward the urgent and elective management of cerebrovascular disease.

In recognition of his contribution to local and national cerebrovascular care, Dr Welch was appointed as the inaugural holder of the Duke Samson Chair in Neurological Surgery in 2015. He also serves as the Director of the UT Southwestern Microvascular Laboratory and routinely instructs residents and colleagues alike in surgical and endovascular approaches to vascular diseases of the brain. His routinely publishes in the national and international literature on topics related to his specialty. He has a developing interest in the development of public policy as it relates to the provision of care to patients with stroke in our nation and affects this policy through elected positions in the national neurosurgical societies.

Dr Welch maintains fluency in Spanish. He is married to Dr JoAnn Welch (Pediatrics). They have 2 daughters. He enjoys reading historical photography, cycling, and educating himself on world cultures through travel.

Dr Welch is a Consultant for Stryker Corporation, Medtronic, Peter Lazic and Microvention

ORCiD: 0000-0002-3821-2485


Dr Christopher J. Winfree

Dr Christopher J. Winfree grew up in Jupiter, Florida, and attended Dartmouth College, where he graduated with high honors in chemistry. After completing medical school at Columbia University College of Physicians and Surgeons in New York, he joined the Department of Neurological Surgery at Columbia University as a resident. Following residency, he completed a fellowship in peripheral nerve surgery in New Orleans, Louisiana, and then a second fellowship in functional and stereotactic neurosurgery in Portland, Oregon.

Currently, Dr Winfree is an assistant professor of neurological surgery at the College of Physicians and Surgeons in New York City, where he specializes in peripheral nerve surgery and pain neurosurgery.

He is a member of several different professional organizations, including the American Association of Neurological Surgeons (AANS), Congress of Neurological Surgeons (CNS), American College of Surgeons (ACS), New York State Neurosurgical Society, North American Neuromodulation Society (NANS), Neurosurgical Society of America (NSA), New York Presbyterian Society of the Alumni, Society of Neurological Surgeons (SNS) Boot Camp Committee, and the CNS Self Assessment in Neurological Surgery (SANS) Editorial Board. He recently completed his term as president of the AANS/CNS Joint Section on Pain.

Dr Winfree has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.


Dr Julian Wolfson

Dr Julian Wolfson is Associate Professor and Director of Graduate Studies in the Division of Biostatistics, School of Public Health at the University of Minnesota. Dr Wolfson's research lies at the intersection of causal inference and machine learning, particularly as applied to large, messy datasets. He has applied my methods to problems such as finding surrogate endpoints in clinical trials, identifying relevant explanatory variables in the presence of correlation and measurement error, predicting the risk of heart attacks using electronic health record data, and understanding human behavior patterns using smartphone sensor data. His collaborative work spans multiple disciplines, including neurology, infectious disease (HIV/Ebola), cardiovascular health, nutrition and obesity, and pediatrics. 

Dr Wolfson has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.

ORCiD: 0000-0002-2032-0875


Dr David Wrubel

Dr David Wrubel has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.

ORCiD: 0000-0003-3307-5298


Isaac Yang MD

Isaac Yang MD is a Board Certified Neurosurgeon and Director of Medical Student Education in the UCLA Department of Neurosurgery, Associate Professor in Neurosurgery, Head and Neck Surgery, and Radiation Oncology in the David Geffen School of Medicine at UCLA, and a Principal Investigator in the UCLA Brain Tumor Laboratory. As the son of South Korean immigrants, Dr Yang grew up in the small town of Lodi, California. Dr Yang’s interest in neurobiology started as an undergraduate as he received his bachelor’s degree with Phi Beta Kappa from the University of California Berkeley. His training followed with a medical degree from the University of California Los Angeles Geffen School of Medicine. Dr Yang completed a neurological surgery residency at the University of California San Francisco, as well as an NRSA NIH funded F32 post doctoral brain tumor research fellowship.

Dr Yang’s clinical focus has been primarily on brain tumors both glioblastoma and skull base tumors. His research efforts have examined antigen expression and manipulation of the immune response to glioblastoma. He has previously been recognized with a UCSF Clinical and Translational Scientist Training Award and the CNS Dandy Clinical Research Fellowship. Dr Yang has been the recipient of several distinguished regional and national awards including the UCSF Medical Center 2010 Exceptional Physician Award, the AANS Integra Brain Tumor Research Award, San Francisco Neurological Society Edwin Boldrey Award for Basic Science Research, American Academy of Neurological and Orthopedic Surgeons Research Award, Kaiser Award for Clinical Research, the national AANS Leksell Radiosurgery Award, and the Tumor Section Ronald L. Bittner Award on Brain Tumor Research.

Dr Yang has published over 200 publications in peer-reviewed journals, authored over a dozen book chapters, and edited over half a dozen published textbooks. Dr Yang is highly sought out by peers, patients and the media for his expertise in neurological diseases and brain health. He has made multiple TV appearances on CBS The Doctors, CNN Dr Drew On Call, and national news outlets. At UCLA, he is currently investigating the utilization of nanoparticles and nanotechnology for the application in brain tumor immunotherapy and vaccines, investigating the role of radiosurgery and Adaptive Hybrid Surgery for skull base tumors, identifying novel biomarkers for meningiomas, and redefining the treatment outcomes for successful skull base surgery in Superior Semicircular Canal Dehiscence. His career is dedicated to improving the care and treatment of all patients with skull base pathology and brain tumors, and he is deeply indebted to his wife Nancy for her support and all of his teachers and mentors who have guided him on this path.

If interested please follow Dr Yang on Facebook at Isaac Yang UCLA Neurosurgery or find his most recent book Service Minded Physician on Amazon.

COI: Consultant for BrainLab and Baxter, Research Grant from BrainLab and Stryker

ORCiD: 0000-0002-5176-5615


Dr Dileep R. Yavagal, MD

Dr Dileep R. Yavagal, MD is director of interventional neurology, and co-director of neuroendovascular surgery, and associate professor of neurology and neurosurgery at the University of Miami & Jackson Memorial Hospitals. Dr Yavagal is an international leader in endovascular therapy for ischemic and hemorrhagic stroke. He is the immediate past-president of the Society for Vascular and Interventional Neurology (SVIN). He is considered a pioneering researcher the field of intra-arterial delivery of stem cells in stroke therapy. Dr Yavagal has received several state and federal research grants to study endovascular stem cell therapies for ischemic stroke using small and large animal models of stroke in his research laboratory. Currently, he is the leading investigator on the steering committee of the first US multicenter clinical trial of intra-arterial delivery of autologous bone marrow stem cells for ischemic stroke (RECOVER Stroke). He was on the investigators steering committee of the MR RESCUE clinical trial. He is also a steering committee member of the currently ongoing SWIFT-Prime randomized clinical trial of endovascular stroke therapy.

Dr Yavagal Consultant for: Cerenovous, Deck Therapeutics , GLG consulting, Guidepoint Consulting, Inneuroco,Inc and Medtronic. He is a consultant Member of Clinical Trial Steering Committee for SWIFT-Prime. He is a speaker for Mosaic Consulting Group and Neural Analytics. He is Rapid Medical Consultant Steering Committee Member, TIGER, trial and is a consultant for Poseydon Medical, LLC and Vascular Dynamics.

ORCiD: 0000-0003-4739-0133


Dr Gabriel Zada

Dr Gabriel Zada is an Associate Professor of Neurosurgery, Otolaryngology and Internal Medicine at the Keck School of Medicine of USC.  He attended UC Berkeley for his undergraduate studies and Medical School at UC San Francisco.  He then went on to complete residency at USC and a fellowship in endoscopic pituitary and skull base surgery at Brigham and Women’s Hospital.  He joined the faculty at USC since 2011, and currently serves as Director of the USC Endoscopic Skull Base Surgery Program, Co-Director of the USC Pituitary Center, and Co-Director of the USC Stereotactic Radiosurgery Program. He is the Associate Program Director of the USC Neurosurgery Residency Program. 

Dr Zada has a keen clinical and academic interest in brain and skull base tumor surgery and has published over 150 peer-reviewed articles on various topics, mostly relating to brain/pituitary tumors and skull base surgery. He co-authored and edited the textbook entitled “The Atlas of Sellar and Parasellar Lesions”. He is an independent NIH-funded principal investigator, whose research laboratory at the Zilkha Neurogenetic Institute focuses on the genomics and epigenetics of brain and pituitary tumors. Dr Zada also serves on the editorial board of The Journal of Neurosurgery.

Dr Zada is consultant for Stryker and for Rebound Therapuetics.

ORCiD 0000-0001-5821-902X


Dr Eric Zager

Dr Eric Zager graduated magna cum laude from Harvard College and received his MD at Stanford University. He completed an internship in general surgery at Columbia University in New York, followed by his neurosurgical residency at the Massachusetts General Hospital in Boston. He won the Galbraith Award in Cerebrovascular Surgery in 1988, and the Young Clinician Investigator Award from the American Association of Neurological Surgeons in 1991. He received a Clinical Fellowship Award from the Congress of Neurological Surgeons to pursue additional training in peripheral nerve surgery at the University of Toronto and at Louisiana State University in New Orleans. He has been on the faculty at Penn since 1989, and currently holds the endowed Neurosurgical Professorship in Academic Excellence at the Perelman School of Medicine at the University of Pennsylvania. He lives with his wife and 3 children in Center City, Philadelphia.

Dr Zager has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.


Dr Jiajia Zhang

Dr Jiajia Zhang is professor of the Department of Epidemiology and Biostatistics at the Arnold School of Public Health at the University of South Carolina. Dr Zhang received her PhD in Statistics specialized in semiparametric estimation for statistical models from Memorial University, Canada in 2007. Her research interests focus on developing methodologies for analyzing epidemiological data, such as South Carolina Cancer Registration data set, South Carolina HIV data set, Women Health Initiative data set, NHANES III data set, SEER data set, geographic data set from census tract. Dr Zhang has cumulated extensive experience in statistical analysis, methods, and interpretation. Till now, she has published more than 100 statistical methodology and consulting papers, and was the PI on NIH-funded grants in methodologies development and Co-I in many NIH grants as the core biostatistician.

Dr Zhahng has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.

ORCiD: 0000-0003-4566-0822


Y. Jonathan Zhang, MD

Y. Jonathan Zhang, MD is a board-certified neurosurgeon at the Methodist Neurological Institute in Houston, TX and assistant professor of neurological surgery at Weill Medical College of Cornell University in New York.

Dr Zhang specializes in comprehensive and innovative treatment of all cerebrovascular disorders, including aneurysm, arteriovenous (AV) malformation, dural and spinal AV fistula, carotid cavernous fistula, cavernous malformation, extracranial and intracranial arterial stenosis or occlusion, hyperacute stroke, and intracranial hemorrhage, with endovascular (catheter-based) and open microsurgical techniques, as well as stereotactic radiosurgery. He is one of the few specialists super-specializing in vascular neurosurgery with both advanced interventional and microsurgical skills in the nation, with experiences in treating more than 1500 complex neurovascular cases.

Dr Zhang's clinical expertise includes minimally invasive microcatheter-based endovascular coiling, balloon remodeling, angioplasty, stent, and biological glues (Onyx and nBCA) techniques in treatment of all neurovascular disorders; minimally invasive microsurgery for neurovascular disease and complex brain and skull base tumors (retractorless and "no-touch" brain surgery); extracranial-intracranial (EC-IC) microsurgical bypass for complex occlusive cerebrovascular disease, moyamoya disease, and giant aneurysms; and endoscopic intraventricular brain and skull base surgery for tumors. His research interests include computational hemodynamic modeling and risk assessment of cerebral aneurysms, and cerebral perfusion reserve assessment in EC-IC bypass.

Dr Zhang serves as ad hoc consultant for Terumo Microvention and Medtronic neurovascular divisions.


Jim Zhong, MD

Jim Zhong, MD is a board-certified radiation oncologist and is an assistant professor of radiation oncology at the Winship Cancer Institute at Emory University in Atlanta, GA. Dr Zhong specializes in the treatment of tumors in the central nervous system and eyes using proton and photon radiation.

Dr Zhong graduated summa cum laude from Emory University, where he earned a BS in biology with highest honors. He subsequently completed medical school at Duke University School of Medicine in Durham, NC. After medical school, Dr Zhong returned to his home city of Atlanta, GA to complete his Radiation Oncology Residency at Emory University. He was selected to serve as chief resident during his final year of residency training.

Dr Zhong's research interest focuses on optimizing treatment outcomes for patients with malignant brain tumors, including glioblastomas, as well as the multidisciplinary management of brain metastases. Dr Zhong has received research funding from the National Institutes of Health and other foundations.

Dr Zhong has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.

ORCiD: 0000-0003-2251-6422